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1. Abstract 
The immune system represents a versatile organ that maintains the integrity of the host. 
However, despite the establishment of immune responses during the acute phase, frequently 
a failure of immunity is observed leading to a chronic state of infection and persisting 
pathogen. This phenomenon often takes place during viral hepatitis. CD8+ T cells are crucial 
mediators of the antiviral immune response, yet, in case of hepatitis C, 70% of patients fail to 
clear the virus and progress towards chronic viral infection. As a consequence, antigen 
specific CD8+ T cells acquire an exhausted phenotype and are not capable to eliminate the 
infection. Studies that aimed to elucidate the causes for an acute failure suggest a local anti-
inflammatory effect of the liver itself. Indeed, anti-inflammatory cytokines are continuously 
expressed within the liver and thus create a tolerogenic environment. However, factors which 
mediate the outcome of immunity remain elusive. To investigate intrahepatic immunity, an in 
vivo transgenic mouse model was used in this study. This model allows inducible expression 
of antigen exclusively in hepatocytes. Moreover, by stochastic events, the model enables to 
establish conditions in which two different amounts of antigen are presented by a defined 
number of hepatocytes.  Thus, the model allows both, the investigation of immune responses 
towards intrahepatic antigens and the impact of different antigen burden towards responding 
CD8+ T cells. By using this model to explore CD8+ mediated  immune responses within the 
liver, this work demonstrates a failure of endogenous CD8+ T cells towards antigen 
expressed by hepatocytes. This failure was also observed, when pro-inflammatory conditions 
were established coincidentally to antigen expression. Remarkably, intrahepatic immune 
responses were only achieved upon transplantation of antigen specific CD8+ T cells into 
antigen expressing mice, as indicated by liver pathology. However, CD8+ mediated 
clearance of antigen presenting hepatocytes was only accomplished if T cells were exposed 
to low numbers of antigen presenting cells. Moreover, clearance of low intrahepatic antigen 
was accompanied by the establishment of protective immunity, while a failure of clearance 
induced systemic exhaustion and depletion of antigen specific CD8+ T cells. Additionally, T 
cell exhaustion was also observed, when in vitro generated T effector cells were challenged 
by high numbers of antigen presenting cells. These results provide new insights into the 
establishment of chronic infections, as they demonstrate a significant role for the 
concentration of antigen to regulate the course and outcome of CD8+ mediated immunity 
within the liver.
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2. Introduction 
2.1 The immune system 
The immune system provides a versatile repertoire of cells to combat infections and to 
maintain the host´s integrity towards threats. These threats include viruses, bacteria, fungi or 
protozoa infection, but also upcoming tumor cells which could compromise the health of the 
host. The immune system consists of two different arms: the innate and adaptive immunity 
(Parkin & Cohen, 2001). All cells of the immune system derive from pluripotent CD34+ 
hematopoietic stem cells within the bone marrow (Fig. 1 and (Murphy, 2012)). The 
hematopoietic stem cells have self-renewal capabilities that are maintained upon cellular 
division (Bryder et al., 2006). Hematopoietic stem cells can differentiate either into a common 
myeloid progenitor or into a common lymphoid progenitor, respectively. The subsequent fate 
of these two different progenitors is determined by specific colony stimulating factors that 
drive the ongoing development of immune cells. All cells that belong to the innate immune 
system (Fig. 1, right panel) derive from myeloid progenitors, while lymphoid progenitors 
reflect the precursors of cells which belong to the adaptive immune system (Fig. 1, left 
panel). One exception are natural killer (NK) cells, as they derive from lymphoid progenitor 
cells, but are functionally dedicated to the innate immune system (Delves & Roitt, 2000a; 
Delves & Roitt, 2000b).  
Cells of the innate immune system are localized at various sites of the host, where they 
sense the occurrence of foreign epitopes that reflect a risk of the host´s integrity. The innate 
immune system responds immediately but unspecifically against any factor that bears a 
pathogen associated molecular pattern (PAMP) or danger associated molecular pattern 
(DAMP). However, although the innate immunity constitutes the first line of defense against 
invading pathogens, it does not provide long lasting protective immunity, since the cells of 
this arm die during an immune response. A protective immunity is established by cells of the 
adaptive immune system, namely T and B lymphocytes. These cells mature within the bone 
marrow (B cells) or the thymus  (T cells) and are transported via the blood and lymphatics 
throughout the whole body (Parkin & Cohen, 2001). Naïve lymphocytes circulate 
continuously via the blood or lymphatic system until they become activated but do not enter 
solid tissues (Ando et al., 1994a; Ando et al., 1994b; Bertolino et al., 2001). By inducing 
apoptosis of infected cells, T lymphocytes are potent effectors against intracellular 
pathogens, while B lymphocytes release antibodies that protect the host against extracellular 
pathogens. 
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During the first response, cells of the innate immune system induce the activation of the 
adaptive immunity. Thus, the innate immune system can be divided into sub parts: 1. 
granulocytes represent effector cells that fight against a pathogen, 2. monocytes (dendritic 
cells (DC), mast cells and macrophages) represent sentinel cells. Due to their capability to 
take up pathogens by macropinocytosis, sentinel cells can be categorized as phagocytes. 
Upon phagocytosis, these cells present pathogen derived peptides to cells of the adaptive 
immune system. Thus, phagocytes reflect a part of the immune system that bridges both, the 
innate and adaptive immune system (Parkin & Cohen, 2001).    
 
Fig. 1: Overview and development of immune and blood cells. Modified according to textbookofbacteriology.net  
 
 
2.2 Innate immune responses towards adaptive immunity 
In order to immediately protect the host against pathogens, cells of the innate immune 
system have the capability of discriminating foreign molecules from self. Furthermore, they 
are localized at positions that represent potential entry ports for pathogens (e.g. mucosa of 
the respiratory tract). Phagocytes bear pattern-recognition receptors (PRRs) that sense a 
broad spectrum of PAMPs or DAMPs on microbes (Medzhitov & Janeway, 1997). Such 
PAMPs are molecules which are conserved on microbes, like lipopolysaccharides (LPS), 
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lipoteichoic acids and mannans on the cell walls of Gram positive or negative bacteria and 
yeast, respectively, yet absent on host cells. Upon ligand binding, PRRs induce endocytosis 
of the pathogen to enhance antigen presentation, nuclear translocation of NFKB and cell 
activation (Muzio et al., 2000). As a consequence, activated cells of the immune system 
release cytokines that induce pro-inflammatory conditions (Parkin & Cohen, 2001). Among 
these pro-inflammatory cytokines, interleukin-1(IL-1), interleukin-6 (IL-6) and tumor necrosis 
factor α (TNFα) are master regulators of inflammation which are rapidly released by virtually 
all cells of the immune system (Malmgaard, 2004). The local increase of these molecules 
recruits innate effector cells to the site of infection in order to avoid systemic spread of the 
pathogen. At the same time, DC endocytose pathogens or pathogen derived peptides within 
the periphery to mediate the transition to the adaptive immunity. DC are professional antigen 
presenting cells (APC) that acquire an activated phenotype upon endocytosis of pathogen 
derived peptides. The activation induces both, maturation of DC and expression of surface 
molecules that allow migration from the inflamed tissue into draining lymph nodes (LN). 
There, activated DC meet naïve antigen specific T or B cells and present pathogen derived 
peptides to them, in order to initiate the adaptive immune response (Crotty, 2011; 
Lanzavecchia & Sallusto, 2001). Responding T cells are activated and acquire an effector 
phenotype (Teff), characterized by the potential to perform lysis of infected cells. Responding 
B cells mature into plasma cells that secrete antigen specific antibodies which neutralize the 
pathogen. However, these defense mechanisms require the access of the immune system to 
the surface of the pathogen and thus are mainly protective against extracellular pathogens, 
mostly bacteria. However, by binding on antigens that are presented on the surface of cells, 
antibodies were also demonstrated to activate NK cells that in turn induce an antibody 
dependent cellular cytotoxicity (Murphy, 2012).   
Intracellular pathogens like viruses in contrast require a rapid protection of the host cell by 
the induction of molecules that interfere with production of viral RNA or DNA. Those 
molecules are type I and type II interferons (IFN) that are rapidly produced by infected cells 
upon recognition of an intracellular pathogen and work in an auto- and paracrine manner. 
Interferons have anti-proliferative capacity, recruit DC to the site of infection and increase the 
expression of MHC class I and II molecules on the surface of infected cells (Malmgaard, 
2004; Parkin & Cohen, 2001; Sen, 2001). As a consequence, infected target cells present 
high amounts of virus derived peptides to antigen specific T lymphocytes which were 
previously primed within draining lymph nodes and subsequently infiltrate the infected tissue. 
CD8+ cytotoxic T cells specifically lyse target cells bearing the cognate antigen on the 
surface by either releasing cytotoxic granules into the cytoplasm of infected cells or by 
inducing a Fas ligand mediated apoptosis of infected cells (Berke, 1995). Upon successful 
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clearance of pathogens, the majority of effector cells undergo apoptosis. This is necessary to 
reconstitute immune homeostasis and is mediated by the induction of anti-inflammatory 
conditions. 
 
2.3 T cell priming within the liver 
The onset of adaptive immunity by professional APC requires the integration of multiple 
signals, namely antigen, co-stimulatory molecules and cytokines. Moreover, the induction of 
a potent adaptive immune response requires both, effector cells (CD8+ T cells or antibody 
producing B cells) and CD4+ T helper cells. CD4+ T helper cells interact with the APC and 
initiate the expression of co-stimulatory molecules to subsequently prime effector cells. This 
model is called APC licensing (Bennett et al., 1998; Ridge et al., 1998; Schoenberger et al., 
1998). The sum of these events takes place within the lymph node and ends in massive 
clonal expansion of antigen specific T cells (Blattman et al., 2002; Parkin & Cohen, 2001).  
Several reports demonstrate that also the liver is a site of T cell activation. Indeed, primary 
activation of T cells has been shown to take place within the liver itself (Ando et al., 1994a; 
Ando et al., 1994b; Bertolino et al., 2001; Bowen et al., 2004). This exception of T cell 
activation is attributed to two parameters, firstly the slow blood flow within the liver and 
secondly the unique structure of hepatic sinusoids (Fig. 2 and (Bogdanos et al., 2013)). The 
liver contains a variety of both, professional and non-professional APC, which were 
demonstrated to be potent activators of CD8+ T cell responses (Bogdanos et al., 2013; 
Ebrahimkhani et al., 2011). Liver resident DC and kupffer cells (KC) are bone marrow 
derived immune cells. KC represent a liver specific population of macrophages that perform 
endocytosis of blood derived antigens and thus function as professional APC. Hepatic 
stellate cells (HSC) are located closely to vascular sinusoids and in particular to the venules 
where they endocytose antigens. Moreover, the liver sinusoidal endothelial cell (LSEC) 
population which is in direct contact to the venous blood has the capability to incorporate and 
subsequently present antigens. Both, LSEC and KC recognize low concentrations of PAMPs 
and respond by induction of pro-inflammatory cytokines such as IL-6 and type I IFN (Kern et 
al., 2010; Wu et al., 2007). The hepatocytes reflect the liver´s parenchym and are non-
professional antigen presenting cells. Importantly, hepatocytes express high amounts of 
MHC class I molecules (Warren et al., 2006) and were also demonstrated to induce T 
lymphocyte activation in vivo (Bertolino et al., 1995; Cebula et al., 2013; Morahan et al., 
1989). These findings are remarkable as priming outside of secondary lymphatic tissues 
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reflects unusual immunological capabilities of the liver according to the classical dogma of 
immunity.  
Yet, although potent immune responses can be induced within the liver, several experimental 
data suggest that the immune response upon priming by hepatocytes is not as efficient as 
responses that were induced by professional APC. Bertollino and colleagues demonstrated 
that T cells are activated towards cytotoxic T lymphocytes (CTL) by hepatocytes in vitro but 
die prematurely (Bertolino et al., 1998; Bertolino et al., 1999). Additionally, in vivo data show 
a failure of immune response upon adoptive transfer of antigen specific CD8+ T cells into 
transgenic mice expressing the cognate antigen under control of the albumin promoter 
(Limmer et al., 1998). This failure can be overcome by coinciding infection of the recipients 
with a liver targeting pathogen, like Listeria monocytogenes (Limmer et al., 1998). In line with 
this observation Derkow and colleagues demonstrated that help-independent priming of 
CD8+ T cells within the liver induces an initial immune response, but fails to maintain this 
response to eliminate the antigen (Derkow et al., 2011). Moreover, by comparing CD8+ T cell 
function upon either priming in the liver alone or priming in both, liver and LN, it was reported 
that liver and LN compete for the priming of T cells (Bowen et al., 2004). Thus, although the 
liver is rich in cells that are capable of shaping immune responses, the liver also seems to 
have a potential to regulate the outcome and fate of intrahepatic immunity. 
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Fig. 2: Microvasculature and anatomy of the liver. Liver sinusoidal endothelial cells (LSEC) shield the hepatic 
parenchym from the venous blood. To mediate uptake of blood derived metabolites, the LSEC barrier is 
intersected by pores that allow a fenestration into the space of Disse. These fenestrae additionally allow a 
transition of migrating lymphocytes from the blood and thus an interaction with antigens presented on 
hepatocytes. Liver specific APC- hepatic stellate cells (HSC) and kupffer cells (KC)-clear the blood from antigens 
and present them to migrating lymphocytes. Adapted from (Bogdanos et al., 2013).  
 
2.4 The liver as an immunological organ 
The liver is a large and vital organ which fulfills the task as the main metabolic organ within 
the body. The liver metabolizes carbohydrates, proteins and lipids, but is also responsible for 
the clearance of toxins and pathogens (Bogdanos et al., 2013; Protzer et al., 2012). While 
fulfilling this task, the liver is exposed to a high amount of metabolites which are transported 
into the liver via the blood from the portal vein (Fig. 2). Indeed, the liver receives 30% of the 
total body´s blood volume per minute (Bogdanos et al., 2013). Additionally, the blood is rich 
in neo-antigens which are mainly derived from food particles. As a consequence, within the 
liver an overload of antigenic stimuli is presented to the immune system and an induction of 
immune response would lead to tissue destruction and metabolic failure. To avoid such 
tissue destruction, the liver is considered to be rather a tolerogenic than an immunogenic 
milieu. In particular this becomes evident by the absence of immunity in response to LPS 
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which is a well-known inducer of pro-inflammatory conditions (Biswas & Lopez-Collazo, 
2009; Protzer et al., 2012). This is of biological relevance since the intrahepatic blood also 
contains high concentrations of endotoxin derived from the commensal gut flora and thus, 
the induction of an immune response has to be impaired. Moreover, the liver shows a 
constitutive expression of anti-inflammatory cytokines such as IL-10 or transforming growth 
factor (TGF). Both molecules were demonstrated to negatively influence T lymphocytes (Holz 
et al., 2008; Knolle et al., 1995; Tinoco et al., 2009) and thus, naïve T lymphocytes are 
forced to overcome these suppressive conditions in response to antigens. 
 
2.5 Immune regulation 
Immune regulation is a crucial mechanism to control the onset of immune response towards 
a variety of antigens which are either harmless or auto antigens from the host itself. 
Especially the onset of immunity towards auto antigens would result in the establishment of 
immune responses against tissues or organs that would result in a systemic failure of the 
host. Well known examples for autoimmunity are chronic diseases such as diabetes type I 
(Roep & Peakman, 2012) or multiple sclerosis (Saxena et al., 2011). Among other immune 
cells, CD8+ T cells which are specific for auto antigens infiltrate the target tissue and exert 
cytolytic function, similar as during infection with a pathogen. To avoid autoimmunity, the 
immune system evolved a mechanism, named negative selection that mediates the deletion 
of auto reactive lymphocytes during the maturation within both, bone marrow (B cells) or 
thymus (T cells). During late stages of T cell maturation within the thymus, epithelial cells of 
the thymic medulla (mTEC) present a broad variety of auto antigens to T cells, that were 
positively selected and thus express a functional T cell receptor (Shi & Zhu, 2013). 
Remarkably, mTEC have the capability to present antigens which are only expressed in 
specialized tissues, e.g. the liver (Klein et al., 1998; Klein et al., 2001). The expression of 
tissue specific antigens is achieved by the transcription factor autoimmune regulator (Aire) 
which controls the expression of tissue specific antigens within mTEC (Anderson et al., 
2002). Upon positive selection, developing thymocytes interact with self-peptide:MHC 
complexes presented by mTEC. If a strong ligation of the TCR to the peptide:MHC complex 
takes place, the responding T cell undergoes activation induced apoptosis to ensure 
negative selection (Starr et al., 2003; Werlen et al., 2003).  
However, some autoreactive T cells escape central tolerance induction within the thymus. 
This is partially due the fact that not all potential self peptides are expressed by mTEC, e.g. 
thyroglobulin which is a tissue specific protein (Murphy, 2012). Thus, the suppression or 
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deletion of T cells that might react against peripheral autoantigens has also to be ensured. 
Similar to central lymphatic tissues, the fate of autoreactive in the periphery might be deletion 
or anergy. The regulation is mediated by professional APC that contribute to peripheral 
negative selection by performing phagocytosis of secreted auto antigens or cellular debris 
within the periphery (Parkin & Cohen, 2001). Since auto antigens do not activate PRR, APC 
are only partially activated and migrate to lymphatic tissue where they interact with specific T 
cells that escaped central negative selection. As this type of antigen uptake does not result in 
complete activation of APC, they do not express the costimuli and pro-inflammatory which 
are required for potent activation of the adaptive immune system. As a consequence, self-
reactive lymphocytes which respond to autoantigen under non-inflammatory conditions are 
clonally deleted by the induction of activation induced cell death (van Meerwijk et al., 1997).    
In addition to central tolerance induction towards auto reactive T cells and the release of anti-
inflammatory cytokines, a third regulative mechanism of immunity has been investigated 
extensively. This form of regulation is executed by a subset of CD4+ T cells, so called 
regulatory T cells (Treg). Treg display a CD4+ CD25+ FoxP3+ phenotype (Fontenot et al., 
2003; Fontenot & Rudensky, 2005) and exert immune suppressive function towards other 
lymphocytes in a dose dependent manner (Sakaguchi et al., 2001). Among the Treg, two 
different populations have been described: on the one hand natural Treg which develop within 
the thymus, and on the other hand induced Treg which are generated in the periphery in 
response to anti-inflammatory cytokines, such as Il-10 or TGFβ (Bluestone & Abbas, 2003). 
To exert suppression, Treg require initial stimulation via the T cell receptor (TCR), indicating 
an antigen dependent specificity. Yet, once Treg are activated, their suppressive capacity was 
reported to be also valid for T cells with a different TCR specificity (Sakaguchi et al., 2001; 
Thornton & Shevach, 2000). Moreover, the antigen dependent activation threshold of Treg 
requires a much lower concentration of antigen as compared to other lymphocytes. In other 
words: even low amounts of antigen have been demonstrated to exert suppressive function 
(Takahashi et al., 1998). Additionally, even low numbers of Treg have been shown to 
efficiently suppress effector T cell responses (Luth et al., 2008). Thus, Treg reflect a 
population of lymphocytes that is highly potent to impair the onset of adaptive immune 
responses. This subset of cells is essential to avoid immune responses against harmless 
antigens, e.g. food derived peptides, or self-antigens from the host. Since the liver is such a 
tolerogenic organ, it is not surprising that Treg are abundant within it (Bogdanos et al., 2013) 
and might be responsible for impairing the onset of a potent immune response within the 
liver. 
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2.6 Liver targeting by pathogens 
The sum of all intrahepatic influences, namely regulatory cells, lack of supporting CD4+ cells 
and the immune suppressive cytokine milieu within the liver render this organ susceptible for 
infections with pathogens. Indeed, several clinically important pathogens target the liver and 
often establish chronic infections. The most relevant liver targeting pathogens are the malaria 
sporozoites, hepatitis B and hepatitis C virus (HBV and HCV) which reside mostly within the 
hepatocytes (Protzer et al., 2012). With about 500 million infected individuals, HBV and HCV 
are the most common causes of chronic liver infections worldwide (Bogdanos et al., 2013; 
Rehermann, 2009; Rehermann, 2013).  
CD8+ T cells were demonstrated to be crucial mediators to cure acute infections within the 
liver (Lechner et al., 2000; Maini et al., 1999). Once an infection is cleared, lifelong antiviral 
immunity is established (Phillips et al., 2010). However, more than 70% of HCV infected 
patients show a failure of acute viral clearance, progressing towards a chronic state of 
infection. Evaluation of antigen specific CD8+ T cells revealed an exhausted phenotype, as 
indicated by expression of inhibitory surface markers, such as programmed death receptor 1 
(PD-1) (Radziewicz et al., 2007), T cell immunoglobulin and mucin domain containing 
molecule 3 (Tim-3) (Golden-Mason et al., 2009; McMahan et al., 2010) or cytotoxic T 
lymphocyte antigen 4 (CTLA-4) (Nakamoto et al., 2009). The failure of the immune system to 
clear acute infections is supposed to depend on multiple host factors, including the 
tolerogenic milieu of the liver itself and the priming of T cells by non-professional APC. On 
the other hand, stealth mechanisms of various viruses significantly contribute to the failure of 
immunity, as viruses display strategies to impair classical endogenous MHC class I 
presentation (Reddehase, 2002). Moreover, viruses were demonstrated to avoid APC 
function by induction of cell paralysis and impairing natural killer cell (NK) mediated target 
cell killing (Reddehase, 2002). Especially upon infection of the liver with both, HBV or HCV, a 
prolonged incubation time of virus is observed. During this time, viremia displays high levels 
but the immune system tolerates the viral particles. In case of HCV infection, the duration 
lasts for around 6 weeks until acute immunity is induced, while in HBV infection the tolerant 
phase can even last for <20 years (Rehermann, 2013).  During this time the virus may 
replicate towards elevated levels and might even acquire mutations that favor to avoid 
cellular immunity. The consequence of T cell exhaustion and failure of antigen clearance in 
response to liver infections is a continuous infiltration of immune cells into the liver and 
release of effector cytokines that induces ongoing tissue destruction. In turn, the liver 
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becomes fibrotic and even hepatocellular carcinomas (HCC) might develop (Melnikova, 
2011). Yet, the fact that acute clearance of virus can be achieved in a small proportion of 
patients gives hope to develop effective treatments. Thus, an understanding of intrahepatic 
immune responses towards liver targeting pathogens is essential. 
 
2.7 T cell exhaustion 
The failure of acute viral clearance and progression towards a chronic state of infection often 
correlates with exhaustion of antigen specific T cells. This phenomenon is not restricted to 
hepatotropic viruses, but rather to a broad variety of viruses, e.g. lymphocytic 
choriomeningitis virus (LCMV) or human immune deficiency virus (HIV) (Letvin & Walker, 
2003; Pantaleo & Koup, 2004; Rehermann & Nascimbeni, 2005; Virgin et al., 2009). When 
compared to T cell tolerance (induced under non-inflammatory conditions) or T cell anergy 
(induced by suboptimal T cell priming) which usually occur in response to auto antigen, T cell 
exhaustion is an unresponsive state of T cells towards pathogens. Exhaustion of T cells can 
be induced despite the presence of strongly activated APC (Cervantes-Barragan et al., 2012) 
resulting in an acute T cell response. Exhaustion of antigen specific T cells prevents optimal 
viral control and is characterized by a variety of phenotypic and molecular changes within the 
antigen specific T cells (Blackburn et al., 2009; Wherry et al., 2007). Antigen specific T 
effector cells are initially generated during the early phases of infection, but show a 
progressive loss of effector function (Zajac et al., 1998). In severe cases even depletion of 
antigen specific T cells is reported (Wherry et al., 2003). A widely used model to study acute 
T cell response vs. exhaustion is infection of mice with lymphotropic choriomeningitits virus 
(LCMV). Depending on the viral strain which is used, adult mice show either viral clearance 
or progress towards chronic infection (Mueller et al., 2007; Wherry et al., 2003). These two 
viral strains differ in only two amino acids within the entire genome and none of these 
mutations affects any of the characterized T cell epitopes (Matloubian et al., 1993). Indeed, 
the early T cell response against both, acute and chronic LCMV strains, displays similar 
kinetics, however, only the acute virus is cleared within 8 days upon infection while the 
chronic strain persists within the host (Wherry et al., 2003). Moreover, clearance of the acute 
virus results in the development of a potent, protective CD8+ memory population (Paley et 
al., 2012). However, studying CD8+ T cell responses towards the chronic LCMV strain in 
mice shows the development and maintenance of an antigen specific progenitor population 
of CD8+ T cells. This population fails to clear the persistent virus but controls viral spread by 
induction of homeostatic conditions between viral load and immune response (Paley et al., 
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2012). The same study reports that such an antigen specific progenitor population is also 
present in chronic HCV patients and is responsible to control viral replication within the 
patient. Yet, these cells differ phenotypically from memory cells as they are positive for PD-1, 
Tim-3 and other exhaustion markers. This phenotype led the authors to the hypothesis that 
the ongoing effector function in response to the virus might lead to a slow decay of this 
progenitor cells. In conclusion, the progression towards a chronic state of infection is 
assumed to be a consequence of T cell exhaustion that takes place in the early phase of 
infection. In contrast to this hypothesis, clinical observation of chronically infected HIV 
patients show improved T cell function upon successful reduction of viral replication. As a 
consequence, antigen specific T cells face lower amounts of antigen and the exhausted 
phenotype is reverted towards a CTL (Day et al., 2007; Streeck et al., 2008). A clinical study 
on acutely HCV infected health-care workers indicates a correlation between initial inoculum 
and outcome of disease. Patients with low inoculum show viral clearance upon acute 
infection, while patients with high load of viral particles progress towards a chronic state 
(Thimme et al., 2001). These observations indicate a regulation of T cell responses which is 
mediated by the amount of antigen itself. 
Indeed, in vivo models, in which T cells are exposed to low amounts of chronic LCMV, 
demonstrate the amount of antigen to be the cause of T cell exhaustion (Mueller & Ahmed, 
2009; Richter et al., 2012). The authors achieved low amounts of antigen by restricting 
antigen presentation to DC. During the initial response, enhanced antigen specific T cell 
clones and improved T cell function were observed. Yet, due to the chosen settings, the virus 
could not be eliminated and thus, T cells were continuously exposed to sustained antigen 
and became exhausted. However, these data imply that the quantity of antigen is the 
consequence of T cell function and thus, decides about either acute clearance or chronic 
progression. Still, it remains elusive, whether the antigen amount indeed is a regulator of T 
cell responses. 
 
2.8 Elucidation of intrahepatic immunity 
To investigate the onset and progression of T cell responses within the liver, transgenic  
mouse models have been established in which target antigens are exclusively expressed on 
hepatocytes (Buxbaum et al., 2008; Derkow et al., 2007; Morahan et al., 1989; Schonrich et 
al., 1992; Wuensch et al., 2006). The disadvantage of these models is that the immune 
system considers the target antigen to be `self ´ as it is expressed from birth onwards and 
thus, is tolerated by the immune system (Delves & Roitt, 2000a; Delves & Roitt, 2000b; Miller 
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& Basten, 1996). A different approach to study intrahepatic immunity is either the transfer of 
hepatotropic viruses that express the target antigen, e.g. adenovirus or the hydrodynamic 
injection of DNA that is accompanied by hepatocyte specific uptake (Huang et al., 2012; 
Stabenow et al., 2010; Wohlleber et al., 2012; Yang et al., 2002). However, both protocols 
result in only a partial transduction of hepatocytes and thus, only affect a small amount of 
antigen presenting cells. Additionally, these approaches do not reflect clinical cases since the 
immune system is capable to clear both, adenovirus and the injected DNA which differs from 
infection with HBV and HCV. Furthermore, viral and non-viral gene transfers were shown to 
be accompanied by severe inflammation and liver damage which might mask immune 
responses towards antigens presented on hepatocytes (Hartman et al., 2007; Racz et al., 
2011). Taken together, there is an urgent need for animal models which exhibit the following 
characteristics: 1. allow the investigation of immune responses towards antigens exclusively 
present on hepatocytes; 2. prevent stimulation of innate immunity to achieve specific 
interactions between CD8+ T cells and the target cell; 3. provide the opportunity to 
specifically analyze factors and pathways that lead to the induction of T cell anergy, 
tolerance or exhaustion as often reported within several infectious diseases.  
 
2.9 Aim of the study 
The liver has been demonstrated to be a potential niche for clinically relevant pathogens to 
establish infections (Protzer et al., 2012). Despite the demonstration of CD8+ T cells to be 
essential regulators within intrahepatic immunity, infection with HCV often leads to viral 
persistence and exhaustion of antigen specific T cells. The factors that determine acute viral 
clearance vs. chronic progression are thought to depend on the tolerogenic milieu of the 
liver, but largely remain elusive. Studies have already suggested a correlation between initial 
inoculum of antigen and outcome of immune responses (Thimme et al., 2001).  
The focus of this study is the characterization of determinants that govern the efficiency of 
CD8+ T cell mediated immune responses within the liver.    
By using a double transgenic Ova x CreERT2 mouse model that mimics de novo expression 
of the antigen Ovalbumin exclusively in hepatocytes (Sandhu et al., 2011), the induction of 
endogenous CD8+ T cell responses towards antigen presenting hepatocytes was 
investigated. This model is a sterile model of infection as the expression of antigen is 
restricted to hepatocytes and does not result in the activation of the innate immune system 
(Sandhu et al., 2011). By providing pro-inflammatory conditions coincidental to de novo 
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expression of antigen it was focus of investigation whether CD8+ mediated immunity can be 
established. Moreover, the use of antigen specific CD8+ in allogenic transplantation 
experiments aimed to investigate the influence of different antigen quantities towards 
intrahepatic CD8+ T cell responses, as well as the subsequent fate of provided antigen 
specific CD8+ T cells. Additionally, it was compared if the phenotype of antigen specific T 
cells (naïve vs. pre-activated) influences the onset and progression of liver immunity.  
The controlled investigation of CD8+ T cell responses towards the target cells of hepatotropic 
viruses in absence of side effects by the innate immune system would significantly contribute 
to the understanding of early events upon liver infection. Moreover, elucidation of 
mechanisms that prevent acute clearance of antigen and induce T cell exhaustion might 
reveal new aspects of therapeutic treatments that could improve the function of CD8+ T cells 
under exhaustive conditions.    
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3. Results 
3.1 Hepatocyte specific expression of Ova within transgenic mice 
3.1.1 Generation of double transgenic mice to achieve hepatocyte specific antigen 
expression 
The transgenic mouse model Ova x Cre (Cebula et al., 2013; Sandhu et al., 2011) allows 
studying immune responses towards hepatic antigens without contribution of the innate 
immune system. The model is based on heterozygous Ova mice which encode a fusion 
protein comprising three components: 1. hsp 73 capturing N-terminal viral J domain of SV40 
Tag (cT77); 2. 108 aa residue of Ova (aa246-353) with well characterized Kb- and Ad/b-
binding epitopes (specifically recognized by OT-I and OT-II cells) and 3. a GFP reporter 
protein. The fusion gene is integrated in reverse orientation to the Rosa26 promoter and 
thus, is inactive. Activation of the transgene can be achieved by expression of Cre 
recombinase which will recombine the inversely orientated loxP sites which flank the 
transgene (Fig. 3A). Tissue specific activation is achieved by mating the Ova mice to 
AlbCreERT2  transgenic animals that express a tamoxifen (Tam) inducible CreERT2 
recombinase (abbreviated with Cre in the following) under the hepatocyte specific Albumin 
promoter (Schuler et al., 2004). Antigen expression in double transgenic Ova x Cre mice is 
induced by treatment with Tam (Fig. 3A upper panel and (Cebula et al., 2013)). Upon 
application of Tam, Cre translocates into the nucleus of hepatocytes and mediates the 
recombination, resulting in reversion of the antigen cassette and activation of expression 
(Fig. 3A). The Cre mediated recombination is reversible as long as Tam is present within the 
blood circulation, thus both an antisense and a sense mRNA of ova are co-expressed (Fig. 
3A). Eventually, when a pulse of Tam is applied and finally cleared, the orientation of ova 
becomes fixed leading to theoretically 50% of hepatocytes expressing the antigen (ON 
state), whereas 50% remain in the OFF state (Fig. 3 B2). Both orientations of ova can be 
determined by qRT-PCR, using specific primers that specifically generate a PCR product in 
the ON state (primer pair 1a/4a) or in the OFF state (primer pair 3a/4a), respectively (Fig. 3A 
and (Cebula et al., 2013)). 
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Fig. 3: Overall scheme of hepatocyte specific antigen expression in Ova x Cre mice. (A) In single transgenic Ova 
mice the antigen is targeted in the ubiquitously active rosa26 locus and flanked by inversely orientated loxP sites. 
As the orientation of ova is in antisense direction, the epitope is not expressed. Ova mice are bred to AlbCreERT
2
 
(Cre) transgenic mice in which the tamoxifen (Tam) inducible CreER
T2
 recombinase is under control of the 
hepatocyte specific albumin promoter. CreER
T2
 is present within the cytoplasm and requires a Tam mediated 
conformational change to translocate into the nucleus and induce recombination of loxP sites. Thereby, the sense 
orientation of ova is induced and Ova is expressed. The position of primer combinations 1a/4a or 3a/4a is used to 
exclusively detect one of both possible ova orientations by qRT-PCR as indicated. (B) Due to the inverted 
orientation of loxP sites, Tam induced recombination events can occur more than once, thus leading to an ON 
state (sense) or OFF state (antisense), as long as Tam is present. Once Tam is metabolized, the orientation of 
ova becomes fixed, theoretical leading to 50% of hepatocytes within the ON state and 50% of hepatocytes within 
the OFF state.  
 
3.1.2 Ova x Cre mice express different amounts of antigen in a Tamoxifen dependent 
manner  
To analyze the status of antigen expression Ova x Cre mice were sacrificed and liver tissue 
was isolated 14 days upon Tam application. Previous data showed that at this time point 
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Tam is cleared from the circulation (data not shown). qRT-PCR was used to quantify the 
mRNA levels of ova. The primer combination 1a/4a exclusively gives rise to a PCR product 
of ova within the ON state (Fig. 3). The expression levels of ova were related to albumin 
which is exclusively expressed in hepatocytes and served as a cell type specific internal 
control. Quantitative analysis reveals absence of a specific product in Ova single transgenic 
mice which are deficient for Cre (Fig. 4A). Ova x Cre mice that received Tam, display a 
detectable product (Fig. 4A). In agreement with previous data (Cebula et al., 2013) a 5fold 
reduced but still significant expression of ova was also found in Ova x Cre mice without Tam 
treatment (Fig. 4A). This basal expression confirms reports on corresponding 
RosaLuc x AlbCreERT2 mice in which luciferase is expressed in a similar expression cassette 
(Sandhu et al., 2011). The constitutive expression in the absence of Tam is attributed to the 
high expression level of CreERT2 protein that might induce recombination even in the 
absence of Tam. Such a Tam independent Cre activity was previously observed during the 
embryonic and postnatal development in an independent model (Imayoshi et al., 2006). 
The qRT-PCR of Tam induced and non-induced Ova x Cre mice two weeks after single Tam 
application showed two different expression levels of ova mRNA within the liver of Ova x Cre 
mice which would correspond to two different amounts of expressed antigen. The expression 
of antigen per cell is similar in Tam treated and non-treated Ova x Cre mice, since only 
heterozygous Ova mice were used within the experiment. Thus, a single hepatocyte can only 
be in either the ON or the OFF state. Thus, the differences of antigen expression have to be 
considered on whole tissue level but not on cellular level. 
According to the theoretical calculation, the induced expression of ova should correspond to 
a maximum number of 50% hepatocytes within the liver. Since 50% of hepatocytes are 
expected to express the antigen upon Tam administration, the basal expression is expected 
to relate to not more than 10% of hepatocytes. As the expressed antigen is a fusion of Ova to 
GFP (Sandhu et al., 2011) flow cytometry was performed on hepatocytes from Tam treated 
and untreated Ova x Cre mice to quantify the amount of antigen expressing cells (Hillebrand 
and Wirth, unpublished). However, GFP positive cells were not detected. Using whole cell 
extracts in western blot experiments also failed to detect the protein (data not shown). This 
might be due to both, a low expression of ova transcript which is 100fold less than actin 
(Cebula et al., 2013) and the accelerated decay of protein due to the viral J-domain within 
the fusion protein (Sandhu et al., 2011). Thus, sensitive methods as RNA detection seem to 
be more applicable to quantify the amount of ova expression within hepatocytes of Ova x Cre 
mice. However, detection of antigen by whole mount RNA in situ hybridization (WISH) on 
  Results  
34 
 
liver tissue failed, as the probe could not enter the hepatocytes due to the capsule of the liver 
(data not shown). 
Thus, qRT-PCR is the only method to quantify the amount of antigen expressing 
hepatocytes. To determine the frequency of antigen expressing cells, the amount of ova 
transcript was calculated in relation to Ova mice in which 100% of cells are in the OFF state. 
Therefore the primer combination 3a/4a (Fig. 3A) which exclusively gives rise to the 
antisense product of ova was used to determine the expression of antigen. The expression 
values of the Ova single transgenic mice were considered to correspond to 100% antisense 
expression. The values of antisense expression in Ova x Cre mice were lower if compared to 
the 100% non-expressing control, reflecting the basal activation of ova in these mice. The 
abundance of antisense transcript within the liver of Tam treated Ova x Cre mice was 
reduced by ~50% if compared to single transgenic Ova mice (Fig. 4B). These values were 
calculated as decreased percentage of antisense expression which gives rise to 54% of 
hepatocytes expressing ova upon Tam treatment and 14% of hepatocytes expressing ova in 
uninduced Ova x Cre mice (Fig. 4C). 
Taken together, Ova x Cre mice show a Tam dependent expression of antigen, allowing the 
investigation of CD8+ mediated immune responses towards two different antigen loads, low 
and high (corresponding to Ova x Cre mice –Tam and Ova x Cre mice +Tam, respectively 
(Fig. 4D)). 
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Fig. 4: Evaluation of the antigen expression within the liver by qRT-PCR. Indicated mice were either treated with a 
single dose of 50 µg Tam or left untreated. 14 days later mice were sacrificed and liver tissue was isolated to 
purify the total mRNA by column preparation (see: RNA purification from liver tissue). (A) To investigate the 
antigen expression within the liver, qRT-PCR using the primer combination 1a/4a was performed on 250 ng total 
cDNA. Expression of ova was related to albumin expression as internal control. Analysis reveals an expression of 
ova in Tam treated Ova x Cre mice which is 5fold higher than the basal expression in non treated Ova x Cre mice. 
n≥4; p≤0,05 using Mann-Whitney test. (B) To evaluate the percentage of hepatocytes expressing the antigen, 
qRT-PCR was performed on cDNA derived from total liver tissue using the primer combination 3a/4a specifically 
for the antisense product (compare to Fig. 3). The relative expression of an Ova single transgenic mouse was set 
to 100% and used to calculate the percentage of antisense expression in Ova x Cre ±Tam mice (n>/=2). (C) 
Using the values of antisense expression from (B), the percentage of expressing hepatocytes was calculated. (D) 
Scheme of different antigen burden in the liver of Ova x Cre mice. 10% (left panel) or 50% (right panel) of 
hepatocytes express the antigen dependent on Tam application. Antigen expressing hepatocytes and ova sense 
orientation are depicted in red. The expression per cell is similar in both conditions, but the amount of antigen 
presenting cells within the liver differs, dependent on Tam treatment.  
 
3.2 Immune competence of Ova x Cre mice 
3.2.1 Central and peripheral tolerance are absent within Ova x Cre mice 
Molecular characterization of the underlying mouse model Ova x Cre by qRT-PCR revealed 
basal intrahepatic Ova expression that occurs even in the absence of previous Tam 
application. The basal expression of Ova might be due to leakiness of CreERT2 which has 
previously been demonstrated to occur during embryogenesis in an independent mouse 
model (Imayoshi et al., 2006).  Thus, it was asked if Ova was also expressed within the 
thymus of Ova x Cre mice prior to activation and might induce central tolerance towards the 
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developing T cells (Miller & Basten, 1996). The induction of central tolerance towards Ova 
specific T cells would depend on two events: 1: The transcriptional activity of Aire would lead 
to thymic expression of CreERT2 that is under control of the albumin promoter. 2. The 
leakiness of CreERT2 that is observed within the liver might also be valid within thymic 
epithelial cells. As a consequence, the antisense cassette of ova might be recombined and 
the antigen would be expressed by the ubiquitous Rosa26 promoter in thymic cells in 
absence of Tam. 
Recently, a tetracycline inducible model for Ova expression within the skin which was 
characterized by a certain leakiness that revealed an increased development of Treg and 
reduction of CD4+ Thelper cells in presence of Ova specific CD4+ T cells (OT-II). Accordingly, 
the induction of Treg and reduction of Thelper cells can be considered to be sensitive indicators 
for thymic expression of Ova antigen (Rosenblum et al., 2011). 
To evaluate the unintended presence of thymic Ova expression, Ova x Cre mice were bred 
to OT-II mice. T cells were isolated from thymus, spleen and liver draining LN of uninduced 
OT-II x Ova x Cre mice. Both, OT-II x Ova mice and single transgenic OT-II mice served as 
controls, to proof the absence of Ova expressed from an antisense transcript in the thymus. 
Evaluation of the CD4+ frequencies showed no significant differences among the groups 
(Fig. 5A and data not shown). Gating on CD4+ CD25+ FoxP3+ Treg within the thymus 
showed that the frequencies of Treg were not increased if compared to the controls (Fig. 5B). 
The fact that the Treg population is not increased, excludes both, intrathymic expression of 
Ova and additionally expression of the antisense transcript that might induce central 
tolerance. 
Yet, the leaky expression within the liver, as confirmed by qRT-PCR (Fig. 4A) might result in 
the development of peripheral tolerance. To investigate the mechanisms of peripheral 
tolerance induction, Treg were investigated in both spleen and liver draining lymph node. No 
increased frequencies of these regulatory cells that might impair the onset of intrahepatic 
immunity mediated by CD8+ T cells were detected in the uninduced state (Fig. 5C and D). 
This suggests that the leaky expression of antigen in the liver is ignored by the immune 
system. Moreover, treating triple transgenic OT-II x Ova x Cre mice with Tam did also not 
result in increased Treg frequencies within the liver or spleen if compared to both, uninduced 
triple transgenic mice or OT-II x Ova control mice (data not shown). In addition by inducing 
Ova expression within the liver of triple transgenic OT-II x Ova x Cre mice did not result in 
increased frequencies of CD4+ T cells if compared to both, untreated triple transgenic mice 
and OT-II x Ova controls (data not shown). Since CD4+ T cells are only activated by antigen 
within the context of MHC class II molecules, these results confirm a previous report that 
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hepatocytes do not express MHC class II molecules under physiological conditions (Herkel et 
al., 2003). Moreover, these results indicate that the antigen is not secreted within the present 
Ova x Cre mouse model. 
Taken together, leaky expression of Ova antigen within the thymus can be excluded by using 
a triple transgenic OT-II x Ova x Cre system. This indicates a strict regulation of antigen only 
within the liver. Moreover, by absence of increased Treg cells the presence of peripheral 
tolerance within the liver can be excluded. 
 
 
Fig. 5: Absence of central or peripheral tolerance in Ova x Cre mice. To exclude central or peripheral tolerance 
mechanisms due to the leaky expression of Ova, Ova x Cre mice were bred to transgenic bearing CD4+ T cells 
specific for Ova. Mice were not treated with Tam and T cells were isolated from thymus (A and B) or spleen (C) 
and liver draining lymph node (LN) (D). Isolated T cells were stained for CD4, CD25 and FoxP3 to investigate the 
percentage of Ova specific Treg by flow cytometry. Shown is the mean of n>3 mice per group ±SD. Due to the high 
variation in (B) bars are overlaid with the frequencies of Treg in the thymus of individual mice.  
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3.2.2 Endogenous CD8+ T cells in Ova x Cre mice are tolerated towards Ova 
Upon confirming the absence of central and peripheral tolerance mechanisms in Ova x Cre 
mice it was asked if a CD8+ T cell mediated immune response was established towards 
activation of Ova presentation exclusively in hepatocytes. Thus, Ova x Cre mice were treated 
with Tam or left uninduced to achieve both, high and low expression of antigen within the 
liver. 14 days later mice were sacrificed and liver resident CD8+ T cells were investigated for 
antigen specificity by flow cytometry. This was achieved by staining isolated T cells with a 
tetramer which presents the Ova derived peptide SIINFEKL and is recognized by the T cell 
receptor of antigen specific CD8+ T cells. 
Interestingly, Ova specific CD8+ T cells were not detected in both, Tam treated or nontreated 
Ova x Cre mice (Fig. 8 Ova x Cre +Tam and data not shown). This confirmed previous 
characterization of the Ova x Cre model (Hillebrand and Wirth, unpublished). However, when 
vaccinating the mice by intramuscular application of a plasmid encoding Ova, the 
development of SIINFEKL specific CD8+ T cells was observed (Hillebrand, Cebula and 
Wirth, unpublished). This indicates that the induction of Ova expression on hepatocytes per 
se does not give rise to antigen specific CD8+ T cells. This suggests impairment of the 
development of antigen specific CD8+ T cells. 
 
3.2.3 Liver inflammation by adenovirus 
The lack of tetramer positive T cells upon inducing antigen expression by Tam led to the 
suggestion that the tolerogenic milieu of the liver impairs the development of functional Ova 
specific CD8+ T cells and results in a failure of potent immune response. The observed 
failure of T cell development might be due to the fact that in Ova x Cre mice induction of 
antigen expression is not accompanied with the activation of the innate immune system by 
pathogen associated molecular patterns. Thus, the onset of Ova expression in Ova x Cre 
mice can be considered to occur in the absence of the classical hallmarks of infection such 
as inflammation induced by viral nucleic acids or cell wall debris of microbes (Delves & Roitt, 
2000b; Parkin & Cohen, 2001). The absence of pro-inflammatory conditions upon antigen 
expression rather reflects a sterile infection and might compromise the development of a 
functional T cell response. Thus, it was investigated if activation of the innate immune system 
coincidental to antigen expression would allow establishing a functional T cell response, 
thereby complementing the sterile model Ova x Cre. To test this hypothesis, pro-
inflammatory conditions were established within Ova x Cre mice by a simultaneous infection 
with a recombinant non-replicating adenovirus. Adenoviruses have been shown to be 
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preferentially hepatotropic in vivo (Hegenbarth et al., 2000; Sprinzl et al., 2001; Stabenow et 
al., 2010; Wuensch et al., 2006; Wuensch et al., 2010). Moreover, adenoviruses have the 
advantage to be non-replicating in vivo if the E1 region is deleted and thus can be either 
used as vectors to deliver genes (Arbuthnot et al., 1996; Bao et al., 1996) or to induce an 
inflammation without establishment of a persistent state. 
To induce CD8+ mediated T cell responses within the liver, Ova x Cre and BL/6 mice were 
treated with Tam or left untreated. Simultaneously to Tam application mice were infected i.v. 
with 1 x 1010 pfu to achieve both, Ova expression and stimulation of the innate immune 
system at the same time. To monitor the route of infection, a recombinant adenovirus 
encoding luciferase and GFP (AdLucGFP) was used. The animals were monitored by in vivo 
bioluminescence measurement to detect virus encoded luciferase (for detailed description 
see 7.5.1.2 In vivo bioluminescence imaging). In vivo bioluminescence imaging on day 3 
upon infection confirmed successful infection and indicated liver tropism of the adenovirus. 
All mice that were infected with virus showed a specific signal for luciferase in particular in 
the center of the body whereas no luciferase was detected in uninfected mice (Fig. 6A). 
Following the kinetics of infection by bioluminescence in vivo imaging showed a peak of 
signal on day 7 in all groups that declined by day 12 (Fig. 6B). Uninfected mice remained 
negative for luciferase over the whole time of experiment. This kinetic indicates a transient 
infection of the liver as expected from a replication-incompetent vector. 
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Fig. 6: Route of adenoviral infection. Ova x Cre or BL/6 mice were infected with 1 x 10
10
 pfu AdLucGFP on day 0. 
Ova expression was induced by application of 8 mg Tam on day -2 and -1. To confirm adenoviral infection in vivo 
bioluminescence measurement was performed on day +3, +7 and +12 upon infection. (A) Representative images 
of individual mice on day 3 (n= 3 mice/ group). (B) Kinetic of luciferase expression upon infection of mice as 
determined by quantification of in vivo bioluminescence measurement on indicated time points (n=3 mice/group).  
 
To confirm the liver tropism of adenovirus and the induction of CD8+ mediated liver 
pathology, serum alanine amino transferase (ALT) levels were monitored on different stages 
relative to infection. The enzyme ALT is preferentially located within the cytoplasm of 
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hepatocytes and is released into the blood upon hepatocyte damage. Thus, ALT is often 
used in the clinics to determine the health status of the liver during infection (Rehermann, 
2009; Stabenow et al., 2010). 
All mice displayed physiological levels of ALT prior to infection, as indicated by serum values 
below 40 U/L (Fig. 7). In line with other reports (Huang et al., 2012; Wohlleber et al., 2012), 
increased levels of ALT were detectable in all groups of mice that were infected with virus on 
day 7 upon infection. Liver damage was monitored until day 14 when the experiment was 
finalized and mice were sacrificed. Analysis of ALT levels at this timepoint indicated ongoing 
liver pathology (Fig. 7). In comparison, uninfected control mice did not show elevated ALT 
levels, irrespective of Tam treatment (Fig. 7). Taken together, the data confirm that infection 
with adenovirus induces a specific intrahepatic immune response, suggesting the induction 
of pro-inflammatory conditions by adenovirus. 
 
 
Fig. 7: Adenoinfection specifically induces liver pathology. Ova x Cre or BL/6 mice were infected with 1 x 10
10
 pfu 
AdLucGFP on day 0. Simultaneously to infection Ova was induced by application of 2 x 8 mg Tam on day -2 and -
1. To evaluate immune mediated liver damage, serum ALT levels were measured at the indicated time points. 
Mean of n=3 mice per group ±SD. The threshold of physiological ALT values (<40 U/L) is depicted by the dashed 
line.  
 
3.2.4 Adenoviral infection induces CD8+ T cells, but does not lead to Ova specific T 
cell clones 
Having confirmed that adenoviral infection results in liver damage, it was investigated if this 
observed immune pathology was mediated by CD8+ T cells. In particular, it was of interest to 
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investigate if these conditions supported the development of Ova specific CD8+ T cells. 
Hence, animals were sacrificed on day 14 upon infection. Analysis of CD8+ T cells by flow 
cytometry showed increased CD8+ frequencies in the liver of all groups of mice that were 
infected with AdLucGFP (Fig. 8). The uninfected control groups displayed ~3-4fold less 
CD8+ T cells within the liver and were comparable to non treated BL/6 animals. However, 
staining with SIINFEKL tetramer showed absence of CD8+/tetramer double positive cells, 
indicating that no Ova specific T cells were induced (Fig. 8). These data suggest that 
induction of Ova expression coinciding with an adenoviral infection induces the generation 
and activation of CD8+ T cells which leads to hepatitis. Yet, the absence of Ova specific 
CD8+ T cells suggests that hepatitis is mainly mediated by T cells specific for adenoviral 
antigens. Together this implies that also these conditions can not overcome tolerance of Ova 
specific CD8+ T cells. 
It was speculated that a competition for epitopes might have been established among T cell 
clones during the acute response against adenovirus. As a consequence, T cells specific for 
Ova might have been outcompeted. To overcome the potential competition, mice were 
treated with Tam again on day 14 upon infection with adenovirus, i.e. a time point when the 
virus had been cleared from the hepatocytes. However, analysis of T cell phenotypes upon 
second induction of antigen expression revealed the absence of SIINFEKL-tetramer positive 
CD8+ T cells (data not shown). Similar results as observed for infection with adenovirus were 
detected, when a replication competent mouse cytomegalovirus (MCMV) was used. If 
compared to adenovirus, MCMV was expected to establish a longer lasting infection. 
Elevated ALT levels were detected in all groups of mice that were infected by MCMV, while 
the controls remained healthy (data not shown). 
Alternatively to infection with viruses, it was investigated whether an unspecific transient liver 
damage induced by i.p. application of CCl4 resulted in development of Ova specific CD8+ T 
cells, which were primed by cross-presenting APC. Although increased ALT levels (≥1500 
U/L) were observed within 24 h upon CCl4-treatment, Ova specific CD8+ T cells could not be 
detected. Finally, unspecific pro-inflammatory conditions were induced by PolyI:C, LPS and 
R848. These synthetic agents are known to activate Toll-like-receptors (TLR) 3, 4 and 7/8, 
respectively (Alexopoulou et al., 2001; Hemmi et al., 2002; Matsumoto et al., 2002; Poltorak 
et al., 1998; Shimazu et al., 1999). Despite an onset of inflammation within the liver via the 
activation of TLR´s neither liver damage, nor development of Ova specific CD8+ T cells were 
observed (data not shown). This suggests an onset of intrahepatic immune response. 
However cross-presentation of Ova and development of Ova specific CD8+ T cells was not 
achieved (data not shown). 
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Fig. 8: Adenoviral infection in mice induces CD8+ T cell immunity without development of Ova specific CD8+ T 
cells. Intrahepatic CD8+ T cells were isolated from AdLucGFP infected Ova x Cre or BL/6 mice on day 14 upon 
infection. CD8+ T cells were analyzed for SIINFEKL-tetramer specificity by flow cytometry. Shown are 
representative FACS plots of each group of mice (n=3/group). To demonstrate tetramer specificity, FACS plots 
from intrahepatic Ova specific CD8+ T cells from an OT-I mouse were implemented subsequently (as indicated by 
#). These cells were not acquired at the same day as the experimental groups.  
 
3.3 Providing antigen specific T cells by allogenic transplantations 
As shown in chapter 3.2, the Ova x Cre model is immune competent, but does not allow the 
development of CD8+ T cell mediated immune responses against Ova which originate from 
endogenous T cell clones. To investigate the onset, course and fate of intrahepatic T cell 
responses, Ova specific CD8+ T cells (OT-I) derived from transgenic allogenic donor mice 
were transplanted into Ova x Cre recipient mice in the following experiments. 
 
3.3.1 Adoptive transfer of Ova specific CD8+ T cells induces acute hepatitis 
Neither induction of intrahepatic antigen expression alone, nor simultaneous induction of pro-
inflammatory conditions could induce a CD8+ T cell mediated immune response against 
Ova. To evaluate whether a CD8+ mediated immune response towards peripheral antigen 
within the tolerogenic milieu of the liver could be achieved, allogenic transplantations of Ova 
specific CD8+ cells (OT-I) were performed. Upon adoptive transfer of 5 x 106 OT-I cells, 
kinetics of immune response were evaluated by measurement of serum ALT. Measurement 
prior to adoptive transfer confirmed that all recipients were healthy (Fig. 9). On day 1 upon 
adoptive transfer a slight increase of ALT was observed in Ova x Cre mice. This increase 
peaked at day 3 upon adoptive transfer in both, high and low antigen expressing Ova x Cre 
mice. The ALT declined to physiological levels by day 6 in both groups. The control groups 
remained healthy throughout the whole experiment (Fig. 9). Unexpectedly, the tissue 
damage was reciprocal to the amount of antigen presented, as the ALT was higher, the less 
the antigen was presented (Fig. 9). 
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In summary, these results indicate a specific CD8+ mediated immune response within the 
liver towards hepatic antigen expressed at high or low frequency. 
 
 
Fig. 9: Adoptive transfer of antigen specific CD8+ T cells induces acute hepatitis. Induction of hepatitis as 
indicated by ALT in the peripheral blood was measured on different time points upon adoptive transfer of 5*106 
OT-I cells to high or low antigen expressing mice. Ova single transgenic mice were also treated with or without 
Tam and adoptively transferred to exclude unspecific side effects due to the treatment.  Statistical analysis was 
performed using Mann-Whitney test with n≥4; *p≤0,0319; **p≤0,0095. The dashed line indicates the threshold of 
physiological ALT <40 U/L.  
 
3.3.2 Clearance of low, but not high antigen is achieved within 13 days 
Adoptively transferred OT-I cells seem to induce a liver damage towards both, high and low 
antigen levels in the liver as determined in chapter 3.3.1 (Fig. 9). This raised the question if 
the acute response and the accompanied liver damage on day 3 would lead to a reduction of 
antigen expressing hepatocytes. A reduction of cell numbers and thus indirectly of antigen 
load would be reflected by a decrease of ova sense mRNA. Thus, liver tissues of Ova x Cre 
and Ova single transgenic control mice were isolated on day 3 upon adoptive transfer of OT-I 
cells and the antigen expression was analyzed by qRT-PCR (compare Fig. 3A, Primer 
combination 1a/4a). As shown previously (Cebula et al., 2013), both, high and low antigen 
levels remained unaltered if compared to non-transferred Ova x Cre mice (Fig. 10). 
In summary, although an intrahepatic immune response is established upon adoptive 
transfer of OT-I cells, antigen expressing hepatocytes are not reduced at early time points. 
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Fig. 10: Antigen burden remains unaltered during acute hepatitis. 3 days upon adoptive transfer of 5 x 10
6
 naïve 
OT-I cells, recipient mice were sacrificed and liver samples were taken for qRT-PCR to determine the amount of 
antigen expression as described above. Despite acute liver damage, analysis no clearance or reduction of 
antigen load within this time period. n≥3, statistical analysis was performed using Mann-Whitney test. *p≤0,0176; 
**p≤0,0061.  
 
Adoptive transfer of OT-I cells to high and low antigen expressing mice was shown to result 
in acute hepatitis accompanied by liver damage (Fig. 9). Yet, determination of antigen 
expressing levels at early stages of immunity has shown that the quantity of intrahepatic 
antigen remained unaltered (Fig. 10). This raised the question if the T cells required a longer 
time period to cure the antigen. To this end, 5 x 106 naïve OT-I cells were adoptively 
transferred to Tam treated and untreated Ova x Cre mice with high or low numbers of 
antigen expressing cells, respectively. Liver tissues were taken from recipient mice on day 13 
to determine the amount of antigen expression by qRT-PCR for the sense orientation of ova 
mRNA. Analysis revealed clearance of antigen on day 13 as indicated by complete 
elimination of ova sense expression in low antigen expressing mice (Fig. 11). In contrast, ova 
mRNA within high antigen expressing mice was still high and remained unaltered if 
compared to mice that did not receive adoptive transfers of OT-I cells (Fig. 11). 
Of note, clearance of low antigen amounts was detected as early as day 7 upon adoptive 
transfers, i.e. a time point when liver damage had already declined (data not shown). Yet, the 
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evaluation of different recipient mice revealed heterogeneous results, as some mice showed 
a clearance, whereas antigen was still expressed in other mice of the same group (data not 
shown). This indicates that clearance of low antigen started during the transient response but 
the kinetics of clearance varied among individual mice. 
Taken together, the capability of CD8+ T cells to clear low but not high antigen amounts 
within the liver suggest a regulative mechanism of the antigen itself towards the immune 
response. 
 
Fig. 11: Clearance of low antigen is achieved within 13 days upon adoptive transfer of naive OT-I cells. 13 days 
upon adoptive transfer of 5 x 10
6
 naïve OT-I cells, recipient mice were sacrificed and liver samples were taken for 
qRT-PCR to determine the amount of antigen expression using the primer combination 1a/4a. Low amount of 
antigen becomes cleared, if compared to non-transferred Ova x Cre mice. Mean of n> 4 mice/ group ±SD; p= 
0,0012; ns= non-significant; Mann-Whitney test. Expression values of non- transferred Ova x Cre mice (-OT-I) 
correspond to data as shown in Fig. 4A .   
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3.3.3 High intrahepatic antigen loads impair acute clearance 
The data above indicate a failure of adoptively transferred T cells to clear high intrahepatic 
antigen loads. This raised the question whether the failure is due to the fact that the provided 
T cells were naive. To test this hypothesis, 5 x 107 OT-I cells were pre-activated in vitro in the 
presence of 3 µg/ml Ova peptide (Kb/SIINFEKL257-264) 2 days prior adoptive transfer to 
induce an effector phenotype of T cells (Teff). The activated phenotype of T cells was 
analyzed by flow cytometry 2 days upon peptide stimulation. Analysis of T cell frequencies by 
flow cytometry showed a ~5.2fold increase of CD8+ cells, if compared to unstimulated cells 
(compare Fig. 12, upper vs. lower panel). This suggests an antigen specific expansion of 
cells. To evaluate the status of cells in more detail, cells were stained for markers of 
activation. Indeed, cells that were cultured in the presence of SIINFEKL-peptide for 2 days 
showed expression of CD69, CD44 and PD-1 (Fig. 12, upper panel). In contrast, 
unstimulated cells showed only low upregulation of these markers, confirming an antigen 
dependent activation of CD8+ OT-I cells (Fig. 12, lower panel). 
 
 
Fig. 12: Phenotypic characterization of in vitro pre-activated OT-I cells. OT-I cells were cultivated in vitro in the 
presence of 90 µg Kb/Ova257-264 peptide for 2 days (upper panel) or left unstimulated (lower panel). Cellular 
expansion and expression of activation markers CD69, CD44, PD-1 was performed by flow cytometry.  
 
As the peptide dependent expansion and activation of CD8+ OT-I cells were confirmed, 
5 x 106 pre-activated cells were adoptively transferred to Ova x Cre mice expressing high or 
low amounts of antigen within the liver, respectively. Ova single transgenic mice were treated 
with Tam or left untreated and served as controls to exclude immune mediated side effects in 
response to the activated status of T cells. ALT was measured on day 3 upon adoptive 
transfer to evaluate an onset of immune response. If compared to mice that received naïve 
OT-I cells, only a moderate liver damage in both, high and low antigen expressing recipients 
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was observed. Mice displayed slightly elevated, yet not dramatically increased ALT values of 
60 to 75 U/L (data not shown). qRT-PCR on liver tissue isolated on day 13 showed that the 
high antigen load was not affected by adoptive transfer of Teff cells, whereas the low antigen 
load was completely eliminated (Fig. 13A). This led to the conclusion that even responses of 
Teff cells may become impaired by high levels of antigen presented within the liver. Of note, 
adoptive transfer of antigen specific CD8+ T cells to recipients expressing high levels of 
antigen led to significantly higher expression levels if compared to mice without 
transplantation of T cells (Fig. 13A). This might be due to the regenerative capacities of the 
liver (Michalopoulos & DeFrances, 1997; Michalopoulos, 2013). Since adoptively transferred 
OT-I cells induce an initial immune response towards high antigen presenting hepatocytes 
which is accompanied by liver damage, remaining hepatocytes in the ON state might 
contribute to the regeneration of the liver. 
Adoptive transfer of naïve OT-I cells has shown that 5 x 106 cells are capable to clear the low 
antigen load (Fig. 11). As the antigen amount in Tam treated Ova x Cre mice is 5fold higher, 
it was speculated that higher numbers of OT-I cells could clear the induced antigen level. To 
investigate this hypothesis, 5fold more naïve OT-I cells (i.e. 2,5 x 107 cells) were 
administered to Ova x Cre mice expressing high intrahepatic antigen. The experiment was 
done over a time span of 5 weeks with five sequential transfers of 5 x 106 naïve OT-I cells, 
each. This setting was chosen to avoid adverse effects caused by injection of high numbers 
of OT-I cells at once. Low antigen expressing Ova x Cre mice which showed a clearance of 
antigen upon a single adoptive transfer, served as controls to exclude induction of bystander 
hepatitis due to T cell transfer as described in another setting (Beland et al., 2012). 
In agreement with previous experiments (Fig. 9), ALT levels showed a high liver damage on 
day 3 upon the first adoptive transfer of 5 x 106 OT-I cells to low antigen expressing mice, 
whereas a moderate liver damage was observed in high antigen expressing mice (data not 
shown). Upon the second adoptive transfer, low antigen expressing mice displayed 
physiological levels of ALT, indicating the absence of ongoing liver damage and thus 
excluding unspecific effects due to T cell transfer as reported previously by Beland and 
colleagues (Beland et al., 2012). Repeated transfers of naïve OT-I cells to high antigen 
expressing Ova x Cre mice in contrast revealed moderate liver damage upon each adoptive 
transfer as indicated by ALT values of ~100 U/L. These ALT levels remained elevated but did 
not increase over time (data not shown). ALT reached physiological levels on day 16 upon 
the 5th adoptive transfer. Mice were sacrificed and liver tissue was isolated to analyze the 
amount of antigen expression by qRT-PCR. High antigen levels were reduced upon transfer 
of 2,5 x 107 cells, if compared to treatment with 5 x 106 cells (Fig. 13B). However, a 
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significant number of antigen expressing cells remained and thus the high antigen could not 
be cleared completely as compared to low antigen expressing mice. 
In summary, the results indicate that neither improved quality of T cells, nor increased 
quantity of T cells can finally eliminate high numbers of antigen presenting hepatocytes. 
 
 
Fig. 13: High antigen load is not cleared by CD8+ T cells. 2 days prior to adoptive transfer OT-I cells were 
cultivated in vitro in the presence of Kb/Ova257-264 peptide for pre-activation of the cells. 5 x 10
6
 OT-I cells were 
adoptively transferred to Ova x Cre mice expressing high or low antigen within the liver, Ova single transgenic 
mice served as controls. (A) On day 13 upon adoptive transfer liver tissue was isolated for qRT-PCR to determine 
the antigen expression level as described above. n≥4; **p≤0,01, Mann-Whitney test. (B) To rule out adverse 
target vs. effector ratios upon adoptive transfers of naïve cells, the quantity of provided OT-I cells was increased 
5fold. In total 2,5 x 10
7
 naïve OT-I cells were adoptively transferred to high and low antigen expressing mice. To 
avoid side effects by providing high numbers of T cells at once, 5 x 10
6
 OT-I cells were adoptively transferred per 
week.  n≥4; **p≤0,01; Mann-Whitney test. Antigen expression values in (A) of non-transferred Ova x Cre mice 
(-OT-I) correspond to the data as previously shown in Fig. 4A.  
 
3.3.4 Antigen specific T cells are maintained upon clearance of antigen presenting 
hepatocytes 
Adoptive transfer to both, high and low antigen expressing Ova x Cre mice, results in early 
activation and antigen specific proliferation of OT-I cells in liver, spleen and liver draining 
lymph nodes on day 3 upon adoptive transfer (Cebula et al., 2013). Despite initial liver 
damage a clearance of antigen was only achieved by cells exposed to low antigen levels. 
High amounts of antigen, in contrast, remained unaffected if a single dose of naïve OT-I cells 
was provided (compare chapter 3.3.2 Clearance of low, but not high antigen is achieved 
within 13 days). This raised the question about the fate of OT-I cells exposed to different 
numbers of antigen as presented in hepatocytes of Ova x Cre mice. Thus, total leucocytes 
and OT-I cells in liver and spleen were calculated on day 13 upon adoptive transfer. 
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Calculation of total lymphocytes in the liver showed a significantly increased number of non-
parenchymal cells (NPC) in low antigen expressing Ova x Cre mice if compared to high 
antigen expressing mice or controls (Fig. 14A). The determination of splenic lymphocytes 
showed no significant differences among the experimental groups (Fig. 14B). To determine 
the amount of antigen specific OT-I cells, calculation of total cell numbers was performed by 
staining liver and spleen resident cells for the congenic marker Thy1.1 (Fig. 14C and D). OT-I 
cell numbers were significantly increased in the livers of low antigen Ova x Cre mice if 
compared to mice expressing high amounts of antigen. Numbers of OT-I cells in high antigen 
expressing mice were as high as numbers in control mice, in which no activation of T cells 
was observed (Fig. 14C). As the transferred cells were isolated from spleens of donor mice, 
it was assumed that the cells relocated to the spleen of recipient mice if not activated. 
Indeed, evaluation of splenic resident OT-I cells showed that the highest number was found 
in the control mice (Fig. 14D). A slightly decreased number of OT-I cells resided within the 
spleen of low antigen expressing Ova x Cre mice. In contrast numbers of OT-I cells in high 
antigen expressing mice were significantly decreased (Fig. 14D). 
Taken together, the results suggest maintenance of antigen specific CD8+ cells upon 
clearance of low antigen. T cells remain at the site of primary antigen exposure (i.e. liver) and 
secondary lymphatic tissue (i.e. spleen) of low antigen expressing mice. If T cells remain 
naïve due to absence of stimulating antigen, they seem to home to their initial lymphoid 
organ, the spleen, as seen in control mice, but become depleted if exposed to high antigen 
levels within the liver. 
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Fig. 14: Intrahepatic and splenic located OT-I cells are more abundant in low antigen expressing mice. Tam 
treated and non treated Ova x Cre and control mice were sacrificed on day 13 upon adoptive transfer of 5 x 10
6
 
naïve OT-I cells. Livers and spleens of recipient mice were isolated and tissue resident lymphocytes were purified 
to determine total numbers of leucocytes (A and B) or Thy1.1+ OT-I cells (C and D). Shown is the mean of n≥5 
mice/group; *p≤0,05; **p≤0,01, using Mann-Whitney test.  
 
3.3.5 Exposure to high antigen load induces T cell exhaustion 
The marker CD69 was previously demonstrated to be expressed immediately during T cell 
activation as a de novo synthesized molecule (Castellanos Mdel et al., 2002; Cebrian et al., 
1988). To investigate the presence of an activated phenotype of OT-I cells exposed to 
different antigen loads, OT-I cells were isolated on day 13 upon adoptive transfer and stained 
for CD69. CD69 was significantly upregulated on liver localized OT-I cells exposed to high 
antigen load as shown by the geometric mean fluorescence intensity (geom. MFI). In 
contrast, CD69 was only slightly upregulated on OT-I cells exposed to low antigen levels, 
whereas its expression was still lower on control cells (Fig. 15A). Evaluation of CD69 on 
spleen resident OT-I cells however did not show differences among the experimental groups 
(Fig. 15D). Since only low numbers of OT-I cells were present in high antigen expressing 
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mice they could have been deleted, as a consequence of T cell exhaustion (Wherry et al., 
2003). To investigate if the remaining cells displayed an exhausted phenotype, liver and 
spleen resident OT-I cells were stained for markers of exhaustion on day 13 upon T cell 
transfer. The markers PD-1 and Lag 3 have previously been reported to be expressed on 
exhausted T cells (Jackson et al., 2013; Paley et al., 2012). Liver resident OT-I cells showed 
a significantly higher expression of PD-1 if exposed to high antigen levels. In contrast, the 
expression of PD-1 on OT-I cells exposed to low levels of antigen was not increased if 
compared to control cells (Fig. 15B). Comparing the expression of Lag 3 on control cells to 
cells from low antigen expressing mice, a significant increase was observed in the latter 
group. However, Lag 3 was even higher expressed on liver resident OT-I cells derived from 
high antigen expressors (Fig. 15C). This increased expression of both exhaustion markers 
on OT-I cells exposed to high levels of intrahepatic antigen suggests an induction of T cell 
exhaustion in response to high numbers of antigen presenting hepatocytes. 
Analysis of splenic OT-I cells revealed no differences in the expression of CD69 and PD-1 
among the groups (Fig. 15D-E). Yet, differences were observed by analysis of the 
exhaustion marker Lag 3, which reflects the same results that were made on liver localized 
OT-I cells (Fig. 15E). However, the geometric MFI of Lag 3 on splenic OT-I cells was found 
to be 10fold lower if compared to liver resident OT-I cells (compare Fig. 15C to F). 
In summary, the results indicate an activation of antigen specific T cells in both, high and low 
antigen expressors. Yet, the kinetics of activation appear to be different, as CD69 expression 
is significantly higher on OT-I cells exposed to high antigen amount, which might be due to 
sustained antigen expression. Moreover, high antigen amount seems to induce exhaustion of 
remaining antigen specific T cells in high antigen expressing mice, as determined by PD-1 
and Lag 3. 
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Fig. 15: High amounts of antigen induce exhaustion of antigen specific CD8+ T cells. Antigen specific Thy1.1+ 
OT-I T cells in liver (A-C) and spleen (D-F) were phenotypically characterized by flow cytometry on day 13 upon 
adoptive transfer of 5 x 10
6
 OT-I T cells. Cells were stained for the activation marker CD69 (A and D) and the 
exhaustion markers PD-1 (B and E) or Lag 3 (C and F). Marker expression is depicted as geom. MFI. n≥3; 
*p≤0,05; Mann-Whitney test.  
 
3.3.6 T cells exposed to low levels of antigen produce effector cytokines upon re-
stimulation with target antigen 
Upon antigen dependent activation, T cells gain the potential to produce and release effector 
cytokines such as IFNy or TNFα (Mueller et al., 2013; Obar et al., 2011; Seder et al., 2008). 
To investigate if OT-I cells primed by different amounts of intrahepatic antigen were positive 
for these effector cytokines, intrahepatic and splenic OT-I cells were characterized for their 
functionality on day 13 upon adoptive transfer. In vitro cultivation of liver derived CD8+ T 
cells in the presence of Kb/Ova257-264 peptide induced no cytokine production if OT-I cells 
were exposed to high intrahepatic antigen load (Fig. 16). The cytokine profile of OT-I cells 
(Fig. 16A open graphs) was comparable to unspecific CD8+ T cells (Fig. 16A filled graphs). 
In contrast, strong expression of both, IFNy and TNFα was observed upon peptide 
stimulation of cells that were exposed to low antigen amounts within the liver (Fig. 16A). 
Moreover, these cells were double positive for IFNy and TNFa (Fig. 16). A similar pattern of 
antigen induced cytokine production could be detected in OT-I cells re-isolated from control 
mice (Fig. 16). By quantification of the respective cytokine production a significantly impaired 
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functionality of OT-I cells exposed to high antigen load became evident, if compared to cells 
exposed to low antigen amounts (Fig. 16B). Similar observations were made upon functional 
investigation of splenic derived OT-I cells (data not shown). Of note, unspecific stimulation 
with PMA/Ionomycin that activates the T cells in a TCR independent manner did not show 
differences between OT-I cells derived from high or low antigen expressing mice, 
respectively (data not shown). 
Taken together, the results indicate a protective phenotype of antigen specific CD8+ T cells 
that were primed under low antigen conditions, whereas T cells exposed to high antigen 
burden seem to be exhausted in an antigen dependent manner. 
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Fig. 16: OT-I cells exposed to low antigen levels produce effector cytokines. To evaluate effector function of 
intrahepatic primed Ova specific CD8+ T cells, OT-I cells were isolated on day 13 upon adoptive transfer and 
stimulated in vitro by 2,5 µg OvaSIINFEKL peptide/ ml to induce effector cytokine expression. 2 h upon stimulation 
vesicle trafficking was blocked by addition of Brefeldin A and cells were incubated for additional 5 h in the 
presence of Ova peptide. (A) To analyze production of effector cytokines in response to Ova, cells were stained 
for IFNy (upper panel) and TNFα (middle panel) and analyzed by flow cytometry. The respective cytokine 
expression of OT-I cells (open graphs) was compared to unspecific CD8+ T cells (filled graphs) which were 
considered to be negative in response to Ova. In addition to single production of effector cytokines, cells were 
also investigated for poly production of cytokines (bottom panel). (B) The quantification of effector cytokine 
production as shown in (A) from n≥5 mice/group. **p≤0,01 using Mann-Whitney test.  
 
3.3.7 A protective immunity is established upon antigen clearance 
The maintenance, activated phenotype and capability to produce effector cytokines of OT-I 
cells exposed to low levels of intrahepatic antigen suggests the establishment of a T cell 
memory (Tmem) population (Mueller et al., 2013). Tmem develop upon successful clearance of 
an antigen and respond more rapidly to the same antigen than naïve cells do. Thus, Tmem 
provide a lifelong protection of the host´s integrity (Ahmed & Gray, 1996; Kaech & Ahmed, 
2001). To investigate if a protective immune response was established upon clearance of low 
intrahepatic antigen, Ova x Cre mice were challenged by an in vivo cytotoxic T lymphocyte 
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(CTL) assay (Aichele et al., 1997). In vivo CTL is a well-accepted method to investigate the 
presence of antigen specific T cells in vivo. To this end, splenocytes were isolated from 
unrelated BL/6 donor mice. One half of the splenocytes was pulsed with target peptide and 
reflected the antigen presenting target population. The other half of isolated splenocytes 
remained naïve and served as control population. Both populations were stained with an 
agent that allows tracing of cells (e.g. CFSE). The target population was stained stronger 
(CFSEhi) than the control population (CFSElo), allowing to discriminate between both 
populations. Both populations were mixed in a ratio 1:1 and adoptively transferred to 
recipients that were expected to harbor antigen specific T cells that respond against the 
peptide presenting target population. Since the transferred cells were derived from spleens of 
donor mice, they were expected to home to the same organ within recipients and cause 
infiltration of antigen specific CTL, if present. As a consequence, the antigen specific CTL 
start to kill the target cells by specific lysis. Upon isolation of spleens the day after transfer 
the remaining CFSE stained cells can be purified and the decay of target cells in relation to 
control cells allows an estimation of antigen specific killing mediated by CTL. 
To investigate the presence of Tmem specific for Ova upon clearance of low antigen, high or 
low levels of antigen were induced in Ova x Cre mice, respectively. Mice were adoptively 
transferred with 5 x 106 naïve OT-I cells and subsequently challenged by an in vivo CTL on 
either day 13 or day 27 upon adoptive transfer. Ova single transgenic mice in which OT-I 
cells were maintained, yet not responding to antigen were used as controls. An in vivo CTL 
on day 13 showed the potential of cytotoxic T cells to perform killing of CFSEhi labeled target 
cells in low antigen expressing mice (Fig. 17A). This killing efficiency was significantly 
increased, if compared to mice expressing high levels of antigen. The killing efficiency in high 
antigen expressing mice was comparable to the efficiency observed in the control mice (Fig. 
17A). Similar observations were made, if the same setup was performed on day 27 upon 
adoptive transfer (Fig. 17B). However, if compared to day 13, the killing efficiency was ~3fold 
decreased (compare Fig. 17A to B). 
Taken together, the results of the in vivo CTL suggest that the priming of antigen specific 
CD8+ T cells leads to the establishment of a T cell population that facilitates a rapid and 
functional response against reoccurring antigen. 
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Fig. 17: Protective immunity in the periphery upon intrahepatic T cell priming. To investigate the presence of a 
potential memory T cell response upon intrahepatic priming of antigen specific CD8+ T cells, Ova x Cre mice 
were adoptively transferred with 5 x 10
6
 naïve OT-I cells on day 0. CFSE
lo
 labeled control cells and CFSE
hi
 
labeled Ova presenting target cells were adoptively transferred to recipient mice on day 13 (A) and 27 (B) upon 
adoptive transfer of OT-I cells. Single transgenic Ova mice were used as controls to investigate unspecific killing 
potential of naïve OT-I cells. 18 h upon transfer of CFSE labeled target cells, the spleens of recipient mice were 
isolated and analyzed by flow cytometry for the killing of target cells. The specific killing potential was represented 
by disappearance of CFSE
hi
 cells. To calculate the specific killing efficiency, the ratio of CFSE
lo 
vs. CFSE
hi
 cells 
was determined prior transfer to recipient mice by flow cytometry. **p≤0,01 using Mann-Whitney test (n≥5 mice/ 
group).  
 
3.3.8 Antigen experienced cells infiltrate the liver in response to high antigen 
Priming of CD8+ T cells by low amount of intrahepatic antigen leads to antigen clearance 
and maintenance of protective CD8+ T cells. These observations led to the suggestion that 
CD8+ T cells primed by low amount of antigen were capable to clear high antigen amount, if 
re-challenged. To this end, OT-I cells were adoptively transferred to low antigen expressing 
mice on day -13. Subsequently, high amounts of antigen were induced by Tam application 
on day 0 (Fig. 18A). ALT analysis on day -10 confirmed induction of intrahepatic immune 
response to low levels of antigen (Fig. 18B).  Upon induction of high antigen load in a subset 
of mice, ALT levels were measured again. Analysis of ALT on day 3 showed the absence of 
liver damage, whereas untreated Ova x Cre mice showed physiological levels of ALT (Fig. 
18B). The absence of liver damage at this time point in high antigen expressing mice might 
either be due to a tightly controlled immune response or to induction of exhaustion by high 
antigen load. To test the latter, T cells from liver and spleen were isolated on day 13 and cell 
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counts of OT-I were determined. Quantification of liver derived OT-I cells showed a 
significantly increased number of cells in high antigen expressing Ova x Cre mice if 
compared to low expressors or control mice (Fig. 18C). Analysis of splenic derived OT-I cells 
showed low numbers of OT-I cells in spleens of high antigen expressing mice, whereas ~3-
4fold increased amounts could be found in spleens of low antigen expressing mice or 
controls, respectively (Fig. 18C). 
In summary, clearance of low antigen leads to establishment of a protective T cell population 
which is recruited into the liver upon subsequent challenge with high antigen levels. 
However, the antigen specific T cells fail to induce an ongoing immune response. 
 
 
Fig. 18: T effector cells cannot overcome high intrahepatic antigen load. (A) Overview of the experimental setup to 
investigate T cell priming by low antigen conditions and subsequent challenge with high intrahepatic antigen load 
on the days indicated. (B) Evaluation of immune pathology within the liver as determined by serum ALT levels 
(±SD). Onset of liver pathology was determined by ALT values >40 U/L as indicated by the dashed line. (C) On 
day 13 upon induction of high intrahepatic antigen load cell numbers of OT-I cells from liver and spleen were 
determined (mean of n≥3 ±SD; *p≤0,05; Mann-Whitney test).  
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3.3.9 Subsequent challenge with high antigen load induces T cell exhaustion 
The results shown above indicate an induction of T cell exhaustion that depends on the 
amount of antigen presented within the liver. To test this hypothesis, phenotypes of liver and 
spleen derived OT-I cells were analyzed by flow cytometry on day 13 upon induction of 
antigen load according to the experimental outline in Fig. 18A. Liver localized OT-I cells from 
both, low antigen expressing mice and low antigen expressing mice subsequently challenged 
with high antigen burden, showed a significantly increased expression of CD44 if compared 
to control mice (Fig. 19A). This indicates an activation of the cells due to the priming by low 
amounts of antigen. Evaluation of PD-1 expression showed that PD-1 was upregulated under 
both conditions, high and low antigen amount. The expression of PD-1 was found to be 
significantly different compared to OT-I cells isolated from control mice (Fig. 19B). However, 
the expression of this exhaustion marker was significantly increased on cells which were re-
challenged with high intrahepatic antigen load if compared to low antigen expressing animals 
(Fig. 19). The same difference was observed by evaluation of PD-1 expression on spleen 
derived OT-I cells. Cells which were subsequently challenged by induction of high antigen 
load expressed a significantly higher amount of PD-1, while cells from low antigen 
expressing mice in this organ did not differ if compared to control mice (Fig. 19B). 
Taken together, analysis of OT-I phenotypes upon subsequent challenge with high antigen 
load indicates an induction of T cell exhaustion towards antigen experienced cells which is 
dependent on the amount of antigen the cells were exposed to. 
 
 
Fig. 19: Antigen experienced T cells become exhausted upon exposure to high numbers of antigen presenting 
cells. 5 x10
6
 naïve OT-I were adoptively transferred to Ova x Cre mice, expressing low amounts of antigen on day 
-13. On day 0, a subset of mice was treated with Tam to subsequently challenge Teff cells with high burden of 
intrahepatic antigen load. OT-I cells were isolated from liver and spleen on day 13 upon subsequent challenge 
with a high amount of intrahepatic antigen and analyzed for markers of activation (A) or exhaustion (B) by flow 
cytometry. Shown is the mean of n≥3 mice/group ±SD as depicted by the geom. MFI. *p≤0,05; **p≤0,01; ns= non-
significant; Mann-Whitney test.  
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3.3.10 High antigen load within the liver cannot be overcome by antigen experienced T 
cells 
Subsequent challenge of antigen specific CD8+ T cells with high amount of intrahepatic 
antigen shows enhanced T cell migration to the site where antigen is re-induced. Phenotypic 
characterization of T cells revealed significantly increased expression of the exhaustion 
marker PD-1 and no signs of liver pathology were detected. Yet, the T cell migration into the 
liver raised the question if the amount of antigen expressing cells was reduced by antigen 
specific T cells or whether it remained unaffected. To test, if this enhanced T cell migration 
has an impact on the antigen, the amount of intrahepatic antigen was determined within 
Ova x Cre mice that were treated with Tam upon clearance of low antigen levels. On day 13 
upon induction of high antigen load, Tam treated and untreated Ova x Cre mice were 
sacrificed and liver tissue was isolated to perform qRT-PCR against the sense orientation of 
ova mRNA. The antigen was cleared in Ova x Cre mice that were not treated with Tam (Fig. 
20). However, analysis of antigen expression within Ova x Cre mice in which high amounts of 
antigen were induced upon clearance of low levels showed that ova was expressed to high 
levels (Fig. 20). In accordance with the data above, these results indicate that indeed the 
amount of antigen negatively correlates to T cell function and thus determines intrahepatic 
immune responses. 
 
 
Fig. 20: High amount of antigen cannot be overcome by in vivo primed antigen specific CD8+ T cells. 5 x 10
6
 
naïve OT-I cells were adoptively transferred to Ova x Cre mice, expressing low levels of intrahepatic antigen on 
day -13. On day 0 when antigen was cleared, a subset of mice was with Tam to induce high antigen expression in 
  Results  
61 
 
the liver. On day 13 RNA was isolated from liver tissue to evaluate the amount of intrahepatic antigen upon 
subsequent Tam treatment by qRT-PCR, (mean of n≥4 mice/group ±SD).  
 
3.3.11 Functional failure of antigen experienced T cells exposed to high amounts of 
intrahepatic antigen 
To confirm that T cell exhaustion depends on the amount of intrahepatic antigen, 5 x 106 
naïve OT-I cells were adoptively transferred to Ova x Cre mice expressing low levels of 
intrahepatic antigen as described above (compare 3.3.9 Subsequent challenge with high 
antigen load induces T cell exhaustion). These conditions allow the generation of protective 
immunity by priming antigen specific CD8+ T cells in vivo. As described in chapter (3.3.9 
Subsequent challenge with high antigen load induces T cell exhaustion) a subset of 
Ova x Cre mice was subsequently treated with Tam upon clearance of low antigen. In vivo 
primed antigen experienced OT-I cells were challenged by an in vivo CTL on day 14 upon 
subsequent induction of high antigen load (Fig. 21A). Flow cytometric analysis of target cell 
killing showed that Ova x Cre mice in which low amount of antigen was cleared (compare 
Fig. 20) displayed a high killing efficiency (Fig. 21B). In contrast OT-I cells, that were 
subsequently challenged by high antigen levels showed a killing efficiency that was 
dramatically reduced and comparable to the controls (Fig. 21B). 
In summary, these results indicate that the number of antigen presenting hepatocytes 
governs the CD8+ mediated immune response. While low levels can be cleared and favor a 
potent memory population, high levels of antigen induce T cell exhaustion. 
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Fig. 21: High amount of intraheptic antigen impairs effector function of antigen experienced CD8+ T cells. 5x 10
6
 
naïve OT-I cells were adoptively transferred to Ova x Cre mice, expressing low levels of intrahepatic antigen as 
indicated in (A). OT-I were subsequently challenged by high amounts of intrahepatic antigen in a subset of mice 
and 14 days later an in vivo CTL was performed to investigate Teff function. (A) Experimental procedure to 
investigate effector function of  antigen experienced T cells exposed to high amounts of intraheptic antigen. (B) 
Analysis of specific target cell killing on day 15 upon subsequent induction of high intrahepatic antigen amount. 
CFSE
lo
 control cells and CFSE
hi
 labelled target (Ova pulsed) cells were adoptively transferred to recipient mice on 
day 14. To analyze the killing efficiency, spleens of recipient mice were isolated on the following day and 
analyzed for the presence of CFSE
hi
 cells by flow cytomertry. Shown is the indicidual killing effeiciency from 3 
mice/group. 
 
Discussion 
63 
 
4. Discussion 
4.1 Onset and regulation of immune responses 
Every organism is continuously exposed to microorganisms or mutagenic agents. However, 
severe diseases only occur rarely. The protection against these threats is mediated by the 
immune system that protects the host towards potentially harmful self or non-self factors. To 
ensure the protection of the host, the immune system has to be a very active organ with the 
aim to sense any kind of foreign factor that might reflect a possible threat to the host. Thus, 
the immune system consists of non-static cells which are specialized towards different 
functions (Parkin & Cohen, 2001). The immune system is divided into two major arms which 
are distinguished by speed and specificity of reaction: the innate and adaptive immunity. The 
innate immunity provides an antigen unspecific, but immediate response and is highly 
conserved among animals (Parkin & Cohen, 2001). In contrast, the adaptive immune 
response mediates antigen specific reactions which are tightly controlled but it requires 
several days or weeks to become established (Ahmed & Gray, 1996; Delves & Roitt, 2000a; 
Delves & Roitt, 2000b). Moreover, cells of the adaptive immune system, namely T- and B- 
lymphocytes, have the advantage to develop a memory which provides a vigorous and rapid 
response against a given epitope upon re-infection. Antigen specific B cells release 
antibodies and mediate the humoral response against extracellular pathogens, while cellular 
immunity is directed against pathogens that are characterized by an intracellular lifestyle and 
involves cytotoxic T cells. To exert immune responses, T cells require the presentation of 
pathogen derived peptides in the context of MHC class I or class II molecules, presented by 
the infected cell. 
Especially CD8+ T cells are crucial mediators in the defense mechanism against viruses, 
including hepatotropic pathogens, namely, hepatitis B and hepatitis C virus (Protzer et al., 
2012; Thimme et al., 2001; Thimme et al., 2002). Yet, treatment of liver infections remains a 
major challenge for current medicine. Despite the development of a cellular antiviral immune 
response, ~70% of HCV infected patients display a failure of acute clearance and progress 
towards viral persistence. Therefore, determinants of viral clearance vs. chronic infection 
remain elusive. A major limitation to investigate antiviral immunity in hepatotropic infections is 
the species specificity of both, HBV and HCV, as these viruses strictly infect primates 
(Frentzen et al., 2014; Huang et al., 2012). These facts cause a restricted availability of 
laboratory animals, such as the mouse to reconstitute viral infection and antiviral immune 
responses. 
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To investigate the consequences of viral antigen expression, the transgenic mouse model 
Ova x Cre was designed to mimic the onset of neo-antigen expression exclusively in 
hepatocytes during liver infection within an immune competent mouse model. The model 
expresses the antigen Ova exclusively on hepatocytes upon Tam mediated induction of 
CreERT2 which is integrated into the albumin locus (Sandhu et al., 2011; Schuler et al., 
2004). The expression of Ova is mediated in a stochastic manner, giving rise to 50% of 
hepatocytes expressing the antigen (Fig. 3 and (Cebula et al., 2013)). This model system 
was used within the present study to investigate the mechanisms of intrahepatic CD8+ T cell 
responses. Beside the analysis of T cell priming by non-professional antigen presenting cells 
and the induction of immune response, the influence of different antigen amounts within the 
liver was the specific focus of this work. The analysis revealed that adoptively transferred 
CD8+ T cells are primed within the liver and induce the destruction of antigen presenting liver 
target cells. Low amounts of antigen are cleared and lead to the establishment of memory 
cells, while high amounts of antigen induce T cell exhaustion. 
 
4.2 Impairment of endogenous CD8+ T cell responses in the immune 
competent mouse model Ova x Cre 
The transgenic mouse model Ova x Cre is a sterile model for infection, since antigen 
presentation is restricted to hepatocytes, requires application of Tam and does not depend 
on infection. Since the antigen is not secreted, only MHC class I restricted CD8+ T cells can 
be activated by induction of antigen expression. 
Initial characterization of the Ova x Cre model has shown the development of tetramer 
specific CD8+ T cells upon vaccination. Yet, such antigen specific T cells are absent upon 
induction of antigen by Tam (Hillebrand and Wirth, unpublished). The fact that tetramer 
specific CD8+ T cells are generated upon vaccination implies the absence of a central 
tolerance mechanism within the thymus (Miller & Basten, 1996). Moreover, these data also 
exclude the presence of any peripheral tolerance which might be induced by APC´s in their 
housekeeping role upon uptake of Ova within the periphery (Parkin & Cohen, 2001). Indeed, 
deeper characterization of the Ova x Cre model revealed that the antigen is exclusively 
expressed by hepatocytes and moreover, is not secreted as expected from the design of the 
model. This becomes evident by the following observations: 
 in vitro co-cultivation of OT-I cells with NPC from Tam treated and untreated 
Ova x Cre mice did not result in activation of OT-I cells (Sandhu et al., 2011). If the 
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antigen was secreted, the NPC should have taken it up according to their role as 
cross-presenting cells (Ebrahimkhani et al., 2011).  
 Cross-breeding of Ova x Cre mice to mice bearing CD4+ T cells, which are specific 
for Ova (OT-II), did not result in the development of natural or induced Treg  (Fig. 5).  
 numbers of peripheral OT-II cells were not found to be increased upon both, co-
cultivation with hepatocytes derived from Ova x Cre mice (Hillebrand and Wirth, 
unpublished) and upon induction of antigen presentation in vivo (see chapter: 3.2.1 
Central and peripheral tolerance are absent within Ova x Cre mice and data not 
shown). 
These data imply the immune competence of the underlying Ova x Cre model which is 
characterized by the absence of thymic expression of the antigen. Together, the data confirm 
a specific expression of antigen only in hepatocytes and the absence of cross-presentation 
before initial liver damage by adoptively transferred OT-I cells. However, the results shown 
here do not exclude the induction of cross-presentation on MHC class II molecules upon liver 
damage by CD8+ T cells. To answer this question a double transfer of CD8+ and CD4+ Ova 
specific T cells would be required. 
Moreover, it remains to be elucidated why the antigen expression per se does not result in 
clonal expansion of SIINFEKL-specific CD8+ T cells (Hillebrand and Wirth, unpublished). The 
absence of antigen specific CD8+ T cells upon induction of antigen reflects the situation as 
often observed in patients infected with HBV or HCV. In both cases an incubation period is 
observed during which high titers of virus are present within hepatocytes, but tolerated by the 
immune system (Rehermann, 2013).  This tolerogenic effect is supposed to be established 
by the liver itself. Indeed, by ubiquitous expression of anti-inflammatory cytokines, such as 
IL-10 or TGFß, the liver establishes an immune suppressive environment and thus, prevents 
the onset of immune responses (Tiegs & Lohse, 2010). In addition to the suppressive 
cytokine milieu, liver resident cells of the NPC-fraction were also demonstrated to exert 
suppressive effects on the induction of CD8+ mediated immune responses. Especially the 
LSEC and HSC mediate cell to cell interaction with CD8+ T cells upon priming by 
hepatocytes and veto the previous activation of antigen specific CD8+ T cells, causing a 
tolerogenic phenotype (Limmer et al., 2000; Schildberg et al., 2008; Schildberg et al., 2011). 
Taken together, the underlying mouse model Ova x Cre mimics the situation of patients upon 
viral liver infection. The absence of central or peripheral tolerance indicates the immune 
competence of the model. This is confirmed by the establishment of Ova specific CD8+ T 
cells upon DNA vaccination. Together, these properties render the model to be a useful tool 
to explore intrahepatic immune responses towards neo antigens. The model allows both, 
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applications to overcome the tolerogenic liver milieu and reconstitution of CD8+ mediated T 
cell responses within the tolerogenic liver milieu. 
 
4.3 Applications to overcome intrahepatic tolerance 
Due to the absence of endogenous CD8+ T cell responses upon both, induction of Ova 
within the liver and DNA vaccination, it was speculated that the local environment of the liver 
exerts immune suppression. To overcome a potential intrahepatic peripheral tolerance that 
might impair the development of antigen specific T cells, in this work various pro-
inflammatory conditions were established simultaneously to Ova expression. Yet, none of the 
provided pro-inflammatory conditions led to the development of an immune response 
directed against Ova. When antigen induction was accompanied by infection with adenoviral 
vectors or MCMV, the induction of intrahepatic immunity was induced as indicated by 
increased serum levels of ALT (Fig. 7). Liver localized CD8+ T cells from responding mice 
were increased in frequency, suggesting that these cells mediated the observed liver 
pathology. However, using a SIINFEKL-tetramer showed absence of Ova specific CD8+ T 
cells upon infection with either virus (Fig. 8 and data not shown). This suggests that the T cell 
response is primarily directed against adenoviral or MCVM specific antigens. The absence of 
Ova specific CD8+ T cells suggests that the Ova antigen was ignored by the immune system 
even under pro-inflammatory conditions. This ignorance might be due to a competition 
among immune cells for strong antigens. The establishment of such a competition in this 
work is quite probable. Although 50% of hepatocytes express Ova, the protein is only 
expressed at physiological levels by the Rosa26 promoter (Nyabi et al., 2009) while high 
amounts of virus were used which could cause the T cells to ignore the Ova. This difference 
of available antigens might shift the balance towards adenoviral directed immunity. 
However, it was expected that the immune mediated liver damage in response to infection 
would also result in generation of Ova specific T cells. By uptake of cellular debris upon 
immune responses against adenoviral infected hepatocytes, during the ongoing immune 
response APC should also have cross-presented hepatocyte derived Ova peptide to specific 
CD8+ T cells localized in secondary lymphatic organs. An explanation for the observed lack 
of Ova specific CD8+ T cells might be the dynamics of immune response. Probably, the 
cross-presentation took place at the peak of antiviral response during which adeno specific 
CD8+ cells might outcompete Ova specific cells. To investigate if the use of adenovirus 
would break the suggested peripheral tolerance against Ova, an adenovirus expressing Ova 
protein could be of help. By this application, an immune response against adenoviral 
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epitopes would be established, but also against Ova as the amount of target peptide would 
be much higher than the Rosa26 derived antigen levels. Additionally, cross-priming of Ova 
peptide could be realized by professional APC at the onset of immunity. 
Interestingly, an intrahepatic immune response against hepatocyte derived antigen was only 
established when viruses were used to induce pro-inflammatory conditions. In contrast, 
triggering of TLR´s did not result in liver damage (3.2.4 Adenoviral infection induces CD8+ T 
cells, but does not lead to Ova specific T cell clones). It could be excluded that the TLR 
activation was not sufficient to induce inflammation: By use of a mouse expressing the 
reporter gene luciferase under the IFN-induced Mx-promotor (Pulverer et al., 2010), 
intrahepatic TLR engagement was observed by increased luminescence within the liver (data 
not shown). The absence of intrahepatic immune response upon TLR engagement is 
unexpected, since it was previously demonstrated that PolyI:C induced engagement of TLR-
3 recruits antigen specific CD8+ T cells (LCMVgp33-41) in the liver and leads to tissue 
destruction as determined by increased serum ALT (Lang et al., 2006). However, if 
compared to the present work, Lang et al. made use of adoptive transfer experiments to 
induce T cell infiltration, while TLR in this work were triggered to induce endogenous CD8+ T 
cells. Thus, the discrepancy might be explained by the different numbers of available T cells. 
Taken together, despite the immune competence of the underlying mouse model, the 
induction of Ova expression exclusively in hepatocytes does not lead to the development of 
antigen specific CD8+ T cells derived from the endogenous pool. However, by the use of 
viruses to induce pro-inflammatory conditions the current work demonstrates the capability of 
the endogenous immune system, especially the CD8+ T cells, to mount an immune response 
against liver targeting pathogens. Other reports in contrast, provided antigen specific CD8+ T 
cells by adoptive transfers coinciding with infection (Lang et al., 2006; Stabenow et al., 
2010). The present results indicate that the tolerogenic milieu of the liver can be overcome 
by the endogenous immune system. Yet, the tolerance of the immune system towards 
hepatocyte derived Ova could not be broken by the chosen settings. This failure might 
depend on a lack of supporting Thelper cells, as previously reported in a mouse model for liver 
inflammation (Derkow et al., 2011). Unpublished data from our laboratory show the 
development of antigen specific CD8+ T cells upon plasmid DNA vaccination. These 
tetramer specific CD8+ T cells are localized within the liver and spleen of both, antigen 
expressing mice and controls. Interestingly, these cells do not overcome the high amount of 
antigen, but are not tolerated systemically, as a peripheral challenge of these cells with 
antigen pulsed target cells by an in vivo CTL shows specific killing (Cebula and Wirth, 
unpublished). These data indicate regulative capacities of the antigen itself in controlling the 
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outcome of intrahepatic immune response by either inducing T cell exhaustion or allowing 
clearance of antigen presenting hepatocytes. 
 
4.4 Liver primed T cell responses 
To study CD8+ T cell mediated immune responses towards hepatocyte derived antigen, in 
the second part of this thesis, antigen specific CD8+ T cells were adoptively transferred to 
Ova x Cre mice. It was of interest, if these cells were able to overcome the tolerogenic milieu 
of the liver and might establish a potent immune response in the absence of pro-
inflammatory stimuli. If compared to other tissues, the unique vasculature of the liver allows a 
direct interaction between naïve T cells and antigens presented on MHC class I molecules by 
non-parenchymal cells and hepatocytes, leading to full priming of antigen specific CD8+ T 
cells (Bertolino et al., 2001; Ebrahimkhani et al., 2011; Warren et al., 2006). In contrast to the 
classical hallmark of T cell activation (Bennett et al., 1998; Ridge et al., 1998; Schoenberger 
et al., 1998), the activation of CD8+ T cells within the liver is even mediated in the absence of 
supporting CD4+ T cells (Bertolino et al., 1998; Cebula et al., 2013; Derkow et al., 2011; 
Wuensch et al., 2006). Using the transgenic mouse model Ova x Cre in which antigen 
presentation is restricted exclusively to hepatocytes (Sandhu et al., 2011) it was 
demonstrated that local intrahepatic priming of adoptively transferred CD8+ T cells indeed 
leads to induction of immune mediated liver pathology as indicated by increased serum ALT 
(Fig. 9 and (Cebula et al., 2013)). Since the antigen is exclusively expressed and presented 
by hepatocytes, a contribution of CD4+ T cells can be excluded. Thus, intrahepatic 
recognition of antigen leads to CD4+ independent activation and proliferation of adoptively 
transferred antigen specific CD8+ T cells within the liver, liver draining lymph node and 
spleen (Cebula et al., 2013). The proliferation in lymph node and spleen is assumed to be 
due to the observed liver damage that enhances cross presentation of antigen by APCs 
within secondary lymphatic tissues. However, despite induction of intrahepatic immune 
responses, a reduction of antigen at the peak of liver damage was not observed (Cebula et 
al., 2013). This might reflect an insufficient activation of antigen specific CD8+ T cells that 
leads to partial effector capabilities and failure against hepatic antigens as described by 
Derkow et al., 2011. The peak of ALT is assumed to reflect the highest stalling of 
hepatocytes. Thus, a higher immune mediated death of target cells occurs in low antigen 
expressing mice which might favor enhanced cross-presentation and generation of Teff cells 
that in turn could induce antigen clearance. Clearance of low antigen started as early as day 
7 upon adoptive transfer (data not shown) and was completed in all mice expressing low 
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amount of antigen at day 13 (Fig. 11). The kinetics of this immune response suggest a tight 
regulation of adoptively transferred T cells which reflects the onset of T cell responses under 
native conditions, taking several days to develop (Delves & Roitt, 2000a; Delves & Roitt, 
2000b; Parkin & Cohen, 2001). 
In summary, by transplantation of antigen specific CD8+ T cells to mice expressing antigen 
within hepatocytes, the present work shows the induction of CD8+ mediated immune 
responses within the liver. However, the outcome of intrahepatic immunity depends on the 
amount of antigen the T cells are exposed to. Indeed, only hepatocytes expressing low 
amounts of antigen can be cleared by the immune system. 
It still remains to be investigated if the failure of CD8+ mediated immunity towards high 
antigen burden could be overcome in the presence of supporting CD4+ Thelper cells. Thus, on 
day 2 upon adoptive transfer of OT-I cells, i.e. a time point when liver pathology is induced, 
OT-II cells could be transferred to Ova x Cre mice expressing low or high antigen levels. This 
would help to investigate if the failure to clear high antigen burden is due to lack of CD4+ T 
cells. On the other hand, it could also be possible that the tolerogenic environment of the 
liver induces the development of Treg which might also impair clearance of low antigen if 
antigen specific CD4+ T cells were present. 
 
4.5 Antigen level dependent regulation of T cell responses 
If compared to viral infection in which the concentration of peptide per cell is different, the 
antigen amount in the Ova x Cre model differs in the total number of antigen presenting cells. 
This difference depends on Tam application that leads to 50% of antigen presenting 
hepatocytes, while in non-treated Ova x Cre mice only 10% of hepatocytes express the 
antigen, due to basal activity of Cre (Fig. 4). Within the present work it could be 
demonstrated that the outcome of intrahepatic immunity is dependent on the number of 
antigen presenting hepatocytes. Importantly, while low antigen amount was cleared within 13 
days, neither reduction nor clearance of high antigen was observed (Fig. 11). This failure is 
not due to inefficient T cell priming under high antigen conditions, since investigation of T cell 
proliferation on day 3 upon adoptive transfer revealed an even higher proliferative capacity of 
OT-I cells exposed to high antigen (Cebula et al., 2013). Further the results suggest that T 
cell proliferation does not correlate with the outcome of intrahepatic immune responses, as a 
significantly less severe liver damage is observed, despite stronger T cell proliferation (Fig. 
9). Rather, the results indicate a regulative role for the level of antigen itself to govern the 
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outcome of intrahepatic immune responses. This suggestion is evident by the observation 
that neither improved quality nor higher numbers of OT-I cells were able to overcome the 
high antigen load (Fig. 13). In both settings antigen clearance was not achieved. Although 
high amounts of antigen were significantly reduced (if compared to high antigen expressing 
mice that received 5 x 106 OT-I cells) the immune system could not overcome this burden. 
The same is true for in vitro pre-activated cells which did not reach a reduction of high 
antigen burden (Fig. 13B) and underwent deletion upon adoptive transfer (data not shown). 
This finding is remarkable since the pre-activated cells were considered to have gained an 
effector phenotype and were producing a high amount of the effector cytokines IFNy and 
TNFα that contribute to the eradication of intracellular antigen (Harty et al., 2000; Harty & 
Badovinac, 2002; Wohlleber et al., 2012). 
The present study further shows that the course of immunity is governed by the amount of 
antigen presenting target cells: T cells developed an exhausted phenotype if exposed to high 
amount of antigen, as indicated by significantly increased expression of PD-1 and Lag-3 (Fig. 
15). Indeed, the expression of PD-1 and Lag-3 was previously demonstrated to correlate with 
T cell exhaustion during several chronic infections (Barber et al., 2006; Isogawa et al., 2013; 
Paley et al., 2012; Wherry et al., 2007). Additionally, exhaustion of antigen specific T cells 
was reported by progressive loss of effector cytokine production and deletion of antigen 
specific T cells (Fuller & Zajac, 2003; Virgin et al., 2009; Wherry et al., 2003; Zajac et al., 
1998). These characteristics could also be demonstrated in this work, when antigen specific 
T cells were exposed to high antigen loads within the liver. In contrast, if T cells were 
exposed to low amounts of antigen, antigen specific T cells were maintained at the primary 
site of antigen exposure and secondary lymphatic tissue (see chapter: 3.3.4 Antigen specific 
T cells are maintained upon clearance of antigen presenting hepatocytes). Moreover, T cells 
exposed to low amounts of antigen showed the potential to release effector cytokines and to 
perform killing of antigen presenting target cells within the periphery. These results suggest 
the establishment of a full functional memory population when T cells are primed by low 
amounts of intrahepatic antigen, as indicated by expression of the memory marker CD44 
(Lau et al., 1994). This is in line with other reports which observe the establishment of 
memory cells in response to low levels of antigen, while high amounts seem to drive 
development of short-lived effector T cells (Badovinac et al., 2004; Joshi et al., 2007). Of 
note, SIINFEKL-tetramer specific T cells were still detected within the liver of low antigen 
expressing mice on day 90 upon adoptive transfer (data not shown), i.e. a time point when 
contraction of effector T cells has already taken place upon eradication of antigen (Oehen et 
al., 1992; Razvi & Welsh, 1995). 
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Yet, although these characteristics suggest the establishment of a memory population, the 
exact phenotype of these cells remains to be determined. It would be interesting to 
investigate if these cells were of the central memory phenotype (TCM) or of the effector 
memory phenotype (TEM). If compared to TCM, TEM release effector cytokines such as IFNy 
and display only low capacity to proliferate. A deeper phenotypic characterization of the 
remaining cells within Ova x Cre mice upon antigen clearance might shed light into the 
observation of failed antigen clearance by in vivo generated T cell protection. 
In summary, the results of the present work demonstrate that both, the course and outcome 
of intrahepatic immune responses depend on the number of antigen presenting hepatocytes. 
While high numbers seem to drive T cell exhaustion, low numbers are cleared by the 
immune system and allow the establishment of memory T cells. 
 
4.6 The amount of antigen is the cause for T cell exhaustion 
In this work it was demonstrated that the number of antigen presenting hepatocytes 
determines the outcome of intrahepatic T cell responses. The observation that the immune 
response is the better the lower the antigen load is supported by various reports. Indeed, 
both, experimental data and clinical implications have suggested an inverse correlation of the 
amount of antigen with the outcome of immune responses. In clinical studies on chronically 
HIV infected patients, successful reduction of viral load by antiviral therapy revealed 
improved T cell function (Day et al., 2007; Streeck et al., 2008). A clinical investigation on the 
course of HCV infection suggested a correlation of viral clearance to a low inoculum of viral 
particles (Thimme et al., 2001). Additionally, In vitro cultures of antigen specific CD8+ T cells 
from human demonstrated a critical threshold for the antigen. While T cells exposed to low 
and intermediate levels of antigen showed cytolytic activity, an unresponsive state was 
acquired in response to high concentrations of antigen (Oved et al., 2007; Wolchinsky et al., 
2014). Together, these data imply that it is indeed the initial amount of antigen that governs 
the outcome of immune responses. Moreover, an in vitro model for T cell priming 
demonstrated a mechanism in which virus specific CD8+ T cell function is influenced by the 
amount of antigen (Gehring et al., 2007). In this system naturally HBV infected human 
hepatocytes were co-cultivated with HBV specific CD8+ T cells. While high amounts of HBV 
led to increased production of IFNy and TNFα, limited amounts of antigen stimulated T cell 
degranulation. These data imply different regulative mechanisms depending on the antigen 
amount, yet do not consider the more complex in vivo conditions of the unique liver milieu 
which might affect T cell responses. Hence, the present work demonstrates that different 
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amounts of antigen govern CD8+ mediated T cell responses in vivo. Interestingly, this 
phenomenon is not restricted to the liver, since studies employing a chronic LCMV infection 
model reported a specific impairment of T cell responses towards elevated levels of antigen 
(Mueller & Ahmed, 2009; Richter et al., 2012). In these settings, the authors restricted 
antigen presentation to dendritic cells by deleting MHC class I molecules on other cell types. 
During the initial phase, improved T cell function was observed, as indicated by higher 
proliferative capacity and cytokine release. This improved function might be explained by an 
optimal stimulation of T cells via professional APC. However, according to the chosen 
settings, the antigen could not be eliminated and increased continuously. As a consequence, 
the efficiently induced effector T cells were overwhelmed by sustained exposure to the 
antigen and became severely exhausted (Mueller & Ahmed, 2009; Richter et al., 2012). 
These results suggest that it is the amount of antigen and not the quality of T cells which 
drives T cell exhaustion and thus, persisting antigen. In line with these data, the present 
study implies a role for the antigen and not the milieu of T cell priming to be the key 
modulator of T cell responses. 
Taken together, the regulative capacities of the antigen load towards immune responses 
suggests the presence of a regulative feedback loop by the immune system. In case of high 
antigenic amounts the immune system rather seems to become exhausted and as a 
consequence allows the establishment of persistent infections. This might be of importance 
to accept persistence of the pathogen instead of increased tissue destruction which could 
cause a systemic failure. Thus, the immune system tolerates the pathogen and just performs 
partial control to impair systemic spread of the pathogen. Such a regulative mechanism 
indicates the presence of CD4+ Treg. However, the contribution of these cells in the regulation 
of intrahepatic immune responses in the current model requires further investigation. 
 
4.7 Limitation of T cell memory and development of therapeutics 
Upon efficient clearance of a pathogen by CD8+ T cells, the majority of Teff undergoes 
apoptosis and a few antigen specific T cells remain to establish a memory population 
(Mueller et al., 2013).  Indeed, upon clearance of low antigen, the establishment of a T cell 
memory population was speculated. Moreover, these cells demonstrated immune protection 
upon peripheral challenge by an in vivo CTL, as demonstrated by specific killing of antigen 
pulsed target cells (Fig. 17). It was speculated if these T cells could also perform effector 
function against re-occurring antigen within the liver. Thus, T cells maintained upon 
clearance of low antigen were subsequently challenged with high intrahepatic antigen load 
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(Fig. 18). The high expression of CD44 indicates an efficient generation of memory cells (Fig. 
19A). Surprisingly, the cells failed to react against the high antigen load as indicated by 
unaltered antigen amount (Fig. 20) and developed an exhausted phenotype. However, the T 
cells were not deleted as known from naïve cells exposed to high antigen amount. Rather, 
the maintained T cells are recruited into the liver and seem to remain there within an anergic 
state as they do not perform specific killing of target cells in the periphery. These data 
suggest that high amounts of intrahepatic antigen have not just a negative impact on naïve, 
but also memory cells. 
It remains to be elucidated how fulminant infections, especially those with an initial high 
inoculum and chronic progression, e.g. hepatitis, malaria or tuberculosis, can be controlled 
by the immune system and may lead to cured infection. The findings of the present work 
reflect a specific attention for the development of therapeutic vaccines against hepatotropic 
pathogens. In case of HBV infection a preventive vaccine already exists, but has been shown 
to be ineffective in the chronic state of infection (Rehermann, 2013). Indeed, such a limitation 
is reflected within the present work as efficiently generated memory cells fail to overcome the 
high antigen load. 
 
4.8 Immune regulation during persistent infection 
T cell non-responsiveness towards antigen is characterized by either induction of anergy or 
exhaustion. The differentiation of these two states is not that strict, as both mechanisms 
allow the persistence of the antigen. However, anergy of antigen specific T cells is often 
associated with suboptimal priming of T cells by professional APC under homeostatic 
conditions to impair autoimmunity (Chung et al., 2013; Wolchinsky et al., 2014). In contrast, T 
cell exhaustion frequently takes place under pro-inflammatory conditions, when infectious 
pathogens are present. During chronic viral infections exhausted CD8+ T cells have been 
demonstrated to undergo extensive activation and cellular division due to persisting antigen 
(Casazza et al., 2001; Shin et al., 2007; Wherry et al., 2004). This division is mediated in an 
antigen dependent manner and contrasts to the maintenance of conventional memory T cells 
which are generated upon acutely resolved infection. Based on both, chronically infected 
mice and HCV infected patients it became evident that the maintenance of exhausted T cells 
is controlled by the T-box transcription factor Tbet. The Tbet mediated maintenance of 
exhausted T cells establishes a progenitor pool of antigen specific T cells (Paley et al., 
2012). Although a full eradication of the virus was not achieved, the authors speculated that 
these cells were maintained to control viral spread by induction of steady state conditions 
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between virus and immune system. Such steady conditions would protect the host on the 
one hand from overwhelming high viral titers and on the other hand by enhanced immune 
destruction of the infected tissue that might end in life threatening conditions for the host. 
Hence, it seems as if the immune system has the decision to either resolve an infection or to 
become exhausted in a self-protective mechanism (Paley et al., 2012). However, such a 
progenitor population was not observed in the present study. This might be due to the 
chosen conditions, since antigen specific T cells were adoptively transferred and did not 
derive from the endogenous precursor pool. The adoptive transfer of OT-I cells might lead to 
a rapid activation of all provided cells within a short while and drive their deletion. 
In addition to the supposed self-regulation of effector T cells during chronic infection, one has 
to consider the induction of regulatory immune cells. Indeed, liver infection with HCV has 
been demonstrated to correlate with both, induction and proliferation of Treg. Moreover, the 
amount of Treg positively correlated to viral replication in HCV patients (Cabrera et al., 2004; 
Manigold et al., 2006; Sugimoto et al., 2003). This suggests that Treg play a critical role in the 
progression of viral hepatitis by impairment of CD8+ mediated immune responses. However, 
analysis of the mouse model Ova x Cre during this study did not reveal an induction of this 
immune suppressive cell type, as indicated by the absence of CD4+ CD25+ FoxP3+ cells 
within the liver of mice (data not shown). This suggests that the observed failure of antigen 
clearance in high antigen expressing Ova x Cre mice is mediated by the amount of antigen 
and not affected by regulatory immune cells. However, the results reported here require a 
deeper characterization of other immune regulatory mechanisms that might impair clearance 
of high intrahepatic antigen load. 
The current work shows that not only naïve, but also antigen experienced T cells display a 
failure to overcome high concentrations of antigen in the liver (Fig. 13 andFig. 20). 
Remarkably, this failure is not restricted to the liver, but results in systemic non-
responsiveness of antigen specific T cells, as indicated by in vivo CTL experiments (Fig. 21). 
Upon clearance of low antigen levels, Ova x Cre mice are supposed to establish a memory 
population. If compared to naïve cells, memory cells require only little amounts of antigen to 
become reactivated and additionally, re-activation can also take place in peripheral tissue. 
The lack of potent immune response when T cells re-encounter high levels of intrahepatic 
antigen suggests the presence of other regulative mechanisms to control CD8+ mediated 
immunity in the liver. Therefore, it would be important to investigate the contribution of the 
different cell subsets within the liver. LSEC for example, have been initially described as cells 
that induce an unresponsive state of CD8+ T cells (Diehl et al., 2008; Limmer et al., 2000). 
Later, LSEC were demonstrated to efficiently generate liver primed memory T cells that 
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display a TEM phenotype, if T cell priming takes place during non-inflammatory conditions 
(Bottcher et al., 2013). Although these findings seem to be contradictory, they suggest that 
LSEC display a significant potential to influence the outcome of intrahepatic immunity. Thus, 
they might also exert suppressive function in the current model and modulate the capacity of 
OT-I cells within high antigen expressing Ova x Cre mice. In this line, enhanced expression 
levels of LSECtin-mRNA, a protein which is suggested to impair intrahepatic T cell immunity 
(Liu et al., 2013) - were significantly increased in total liver tissue of Tam treated Ova x Cre 
mice, as indicated by qRT-PCR (data not shown). These results suggest a contribution of 
LSEC to the observed failure of antigen specific CD8+ T cells to clear high antigen loads. 
 
4.9 Conclusions 
In summary, by using the transgenic mouse model Ova x Cre, the present work revealed 
new insights into intrahepatic mediated CD8+ T cell responses. Different amounts of antigen 
allow both, the activation of antigen specific T cells accompanied by the induction of tissue 
damage displaying a transient course. However, the severeness of tissue damage correlates 
inversely to the amount of presented antigen. Low numbers of antigen presenting cells can 
be cleared by the immune system, leading to establishment of a protective, systemic 
immunity. In contrast, high amounts of antigen result in activation of CD8+ T cells, but 
subsequently induce severe exhaustion of responding T cells. These findings might reflect 
the challenge of current therapy to fight pathogens that often establish a chronic state of 
infection and viral persistence. 
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5. Future perspectives and outlook 
The unique feature of stochastic antigen expression in either 10% or 50% of hepatocytes 
illuminated a specific role for the concentration of antigen to regulate liver immunity. Potent 
immune responses were only established upon clearance of low antigen loads and T effector 
cells were exhausted when re-challenged with high antigen loads in the tolerogenic 
environment of the liver. It was assumed that this was a regulatory feedback loop to avoid life 
threatening tissue destruction. Thus, it would be interesting to investigate if the impairment of 
T effector cells is restricted to the liver or if it also takes place in different immune 
suppressive environments. Tumors are an aggressive tissue in which different danger 
signals, so called tumor associated antigens, are established that induce immune responses. 
However, tumors are known to establish a suppressive microenvironment to avoid 
destruction by responding T cells. Thus, upon clearance of low intrahepatic antigen, Ova x 
Cre mice could be challenged by transplantation of Ova expressing tumor cells to create an 
immune suppressive environment apart from the liver. 
If compared to models that rely on infection, a significant advantage of the Ova x Cre system 
is that the amount of antigen is controlled and does not increase by time. Thus, CD8+ T cells 
are challenged by two defined conditions which might be useful to determine molecular 
pathways that are involved in the development of memory T cells, tolerant T cells, anergic T 
cells or even exhausted T cells. To investigate molecular pathways that subsequently 
regulate the fate of T cells upon exposure to antigen or antigen presenting cells that express 
low or high levels of target peptide, adoptively transferred T cells could be re-isolated from 
Ova x Cre mice expressing high or low antigen on different time points upon transfer. 
Investigation of the transcriptome from these cells might help to understand the interplay of 
different molecules in early, intermediate and late stages of T cells that are committed 
towards a specific phenotype. The results of such a transcriptome analysis might allow to 
find molecules that enable a precise discrimination of different T cell subsets (e.g. anergic vs. 
exhausted). Further, they might help to develop therapeutical approaches. One therapeutical 
approach for example is the administration of antibodies that block co-inhibitory ligands on 
target cells to restore function of exhausted T cells (Fisicaro et al., 2012; Isogawa et al., 
2013). If transcriptome analysis would allow the determination of the exact time point when 
such co-inhibitory molecules are expressed, blocking of the interactions could already be 
performed at the onset of immune response. This might even avoid the induction of T cell 
exhaustion. 
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6. Material  
6.1 Equipment 
Tab. 1: List of laboratory equipment.  
Name                                                                         Company 
Autoclave                  Belimed steam sterilizer 6-6-6 HS1 FD 
Centrifuges                  Heraeus Biofuge fresco 
                   Beckmann GS-15R 
                   Sigma 3K20 
                   Heraeus Megafuge 1.0 
                   Thermo Scientific Jouan CR412 
                    Inflexible Rotors GSA, GS3, SS34 
                    Swing Rotor HB4 
Cell acquisition                  BD™LSRII analyzer 
                    BD™Fortessa analyzer  
                    BD™ARIA cell sorter 
Cell counter                   Fuchs-Rosenthal 
                    Neubauer improved 
                    Guava (Millipore) 
Deionized water                             Millipore MilliQ 
Feeding gavage                  Heiland Vet GmbH 
Forceps                   Curved forceps, tissue forceps  
Gel electrophoresis                  Gibco BRL horizontal Gel 
Homogenizer                   MP FastPrep®-24 Lysing Matrix 
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LightCycler®480 for Real Time PCR                          Roche 
Microliter pipettes                  Gilson  
Microscopes                   Leica Labovert FS 
                    Nikon TMS 
                    Olympus BX51TF + Color view camera 
          Illu                                        
Microwave oven                  Whirlpool 
PCR cycler                   T3 Thermo cycler, Biometra 
pH-meter                   Beckman M340 
Photometer nanodrop                                                Spectrophotometer, Peqlab ND-1000
     
Perfusion needles Vasuflo 23G                Dispomed (40023) 
Pipetboy                   Pipetboy IBS Integra Biosciences 
Power supplies                  Biotec-Fischer Phero-STAB 550 
                    Biorad Power PAC 200 
                    Gibco BRL ST 504 
Precision scale                    Sartorius 
Scissors                     Tissue scissors 
Shaker                      Heidolph 
Steel sieves 
Sterile clean benches                                                    BDK-SK 1500  
                                                                                        Sterile Guard Class II Type A/B3,                             
             Baker Company SG 400E 
                                                                            Heraeus, Herasafe, Heraeus HSP 18 
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             Heraeus, Herasafe KS15 
Table top centrifuges                                                     Eppendorf 5417C 
                                                                            Eppendorf 5436 
                                                                            Heraeus Biofuge 13 
Thermomixer                                                                Heraeus Biofuge PICO 17 
                                                                            Eppendorf Thermomixer compact 
U.V. trans illuminator                                                     Hanau 
Vortexer                                                                 Vortex Genie 2, Scientific Industries 
Water bath                                                                 GFL 
Xenogen IVIS 200           Caliper Life Sciences 
4°C refrigerator                      Liebherr 
-20°C freezer                                 Liebherr 
-80°C freezer                                 Thermo Forma 
 
6.2 Chemicals and antibiotics 
Tab. 2: Overview of chemical compounds used in this work.  
Compound                                                    Company                   Catalogue no. 
Agarose (LE)               Biozym                       840004 
Ampicillin     Sigma 
BSA, molecular biology grade                      NEB                            B9000S  
Brefeldin A     eBioscience   00-4506 
Carbon tetra chloride (CCl4)  provided by Prof. Lars Zender, HZI 
ClinOleic 20 % lipid emulsion  Baxter   2573668 
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Direct PCR tail lysis reagent   Peqlab              32-102-T 
Easycoll, density 1,124 g/ml   Biochrom KG  L 6145 
EDTA      Roth 
Glutamine     Serva 
HCl      Roth (37%) 
Heparin     Ratiopharm  3029843 
HEPES     PAA 
Ionomycin     Sigma   I0634-1MG 
Isofluran     Allbrecht GmbH A29951,0025 
Lipofectamine 2000                                      Life Technologies       11668030 
Luciferin                                                        PJK 
MEM      Gibco   61 100-087 
Midori Green                                                 Nippon Genetics        MG04 
Nuclease free H2O    Promega   
Phorbol 12-myristate 13-acetate  Sigma   P8139-1MG 
Proteinase K     Qiagen  19133 
SIINFEKL peptide (10 mg/ ml)  Peptide- and Chemical Synthesis Group HZI 
Streptomycin     Serva 
Sucrose     Roth 
Tamoxifen (10 mg, 30 mg)                           Ratiopharm  9394.00.00 (Zul. Nr.) 
TEP (10 x )     Biochrom 
Tris      Roth 
Trypanblue     Sigma   T8154-20ML93595 
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Viacount solution    Millipore   
 
6.3 Kits  
Tab. 3: List of complete application kits.  
Name                                                                       Company                              Catalogue no. 
Anti-rat/mouse FoxP3 staining Kit   eBioscience   72-5775-40 
BD FACS lysing solution    Becton, Dickinson  349202 
Biomix       Bioline    302004 
CD8a+ Tcell isolation Kit II    Miltenyi, Biotec  130-095-236 
CellTrace CFSE cell proliferation Kit   Beckman Dickinson  554714 
Cytofix/Cytoperm™     Beckman Dickinson  349202 
LIVE/DEAD® Fixable Near IR Dead cell stain kit Invitrogen   L10119 
Nucleobond extra maxi                                            Macherey-Nagel 
QIAquick Gel extraction Kit                                     Qiagen    28706                                  
QuantiTect SYBRGreen PCR Kit              Qiagen   204143 
Ready-To-Go™ You Prime first strand beads GE Healthcare  27-9264-01 
RNase free DNaseI     Qiagen   
 79254 
RNeasy Mini Kit (250)    Qiagen   
 74106 
RNeasy Micro Kit (50)    Qiagen              
 74004 
TOPO TA cloning®     Invitrogen   K4500 
  
Material 
82 
 
6.4 Antibodies 
Tab. 4: Overview of antibodies used. Abbreviations: FC= FlowCytometry, WB= Western blot. For FC, all 
antibodies were diluted in FACS-buffer.  
Epitope Conjugate Dilution Application Company Catalogue No. 
CD3 FITC 300 FC eBioscience 11-003 
CD4 eFluor450 1000 FC eBioscience 48-0041 
CD8 unconjugated 100 µg 
i.p. 
CD8 
depletion 
Dr. S. Weiss  HZI 
CD8 APC 600 FC eBioscience 17-0081 
CD8 PE 200 FC eBioscience 12-0081 
CD8 PerCP Cy5.5 400 FC eBioscience 45-0081 
CD16/ 
CD32 
unconjugated 500 FC/ 
blocking 
Dr. S. Weiss HZI 
CD25 APC 500 FC eBioscience 17-0251 
CD44 APC 1000 FC eBioscience 17-0441 
CD62L APC 4000 FC eBioscience 17-0621 
CD62L PE-Cy7 1500 FC eBioscience 25-0621 
CD69 FITC 300 FC eBioscience 11-0691 
CD69 PE-Cy7 300 FC eBioscience 25-0691 
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CD90.1 
(Thy1.1) 
APC 600 FC eBioscience 17-0900 
CD90.1 
(Thy1.1) 
PE 2000 FC eBioscience 12-0900 
CD223 
(Lag-3) 
PE 300 FC eBioscience 12-2231 
CD279 
(PD-1) 
FITC 300 FC eBioscience 11-9985 
CD279 
(PD-1) 
PE 300 FC eBioscience 12-9985 
Ova MHC 
class I 
H2Kb 
APC 500 FC eBioscience 17-5743 
Chicken 
egg 
Ovalbumin 
SIINFEKL 
unconjugated - WB Sigma Aldrich A6075 
SIINFEKL 
tetramer 
PE 200 FC Beckmann/ 
Coulter  
T03000 
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6.5 Buffers media and solutions 
Tab. 5: Overview of buffers media and chemical solutions used in the present work.  
Substance                                         Ingredients or company no. 
ß-Mercaptoethanol (1000x)  100 mM ß-ME (v/v) in ddH2O 
Erythrocyte lysis buffer  150 mM NH4Cl 
     10 mM KHCO3 
     0,1 mM EDTA 
     pH 7,2-7,4 
FACS buffer    PBS 
     2% (v/v) FCS 
FCS (fetal calf serum)  JRH Bioscience, Biowest 
Glutamine (100x)   29,23 mg/ml Glutamine 
     sterile filtered  
HEPES (1 M)    283,3 g 
     pH 7,2 
     ad H2O 1 l 
Liver digest medium   Gibco Nr. 17701-034 
Liver perfusion medium  Gibco Nr. 17703-038 
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MACS buffer    PBS 
     1% (v/v) FCS 
MEM     Minimum essential medium   
     100 ml HEPES (1 M) 
     8,5 g NaHCO3 
     pH 7-7,4 
     ad H2O 10 l 
Penicillin/Streptomycin (100x) 6,06 mg/ml ampicillin (10000 U/ml) 
     10 mg/ml streptomycin 
     sterile filtered  
     pH 7,4  
     ad H2O 1 l   
PBS     140 mM NaCl 
     27 mM KCl  
     7,2 mM Na2HPO4 
     pH 6,8- 7 
     ad H2O 10 l 
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RPMI     Roswell Park Memorial Institute medium; RPMI powder 
     100 ml HEPES (1 M) 
     1,68 g/l NaHCO3 
     pH 7- 7,4 
     ad H2O 10 l 
Trypsin-EDTA    100 ml TEP-PBS (10 x) 
     ad H2O 1 l 
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6.6 Enzymes 
6.6.1 Restriction enzymes 
Tab. 6: List of endonucleases that were used within the present work.  
Name                                     Stock concentration  Company         Catalogue no. 
ApaLI                                     10000 U/ml                NEB                R0507 
BamHI (high fidelity)              20000 U/ml                NEB                R3136 
BglII                                       10000 U/ml                 NEB                R0144 
BssHII                                      4000 U/ml                 NEB                R0199 
ClaI                                          5000 U/ml                 NEB                R0197 
EcoRI (high fidelity)  20000 U/ml                 NEB              R3101 
MfeI    10000 U/ml   NEB                R0589 
NaeI    10000 U/ml   NEB                R0190 
NcoI  (high fidelity)                 20000 U/ml                 NEB                R3193 
NruI                                    10000 U/ml                 NEB                 R0192 
PstI                                         20000 U/ml                NEB                  R0140 
PvuII               10000 U/ml                 NEB                  R0151 
SacII                                       20000 U/ml                 NEB                  R0157 
StuI                                         10000 U/ml                 NEB                  R0187 
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6.6.2 Enzyme buffers 
Tab. 7: List of buffers used for endonucleases as indicated in Tab. 6.  
Name Concentration Company Catalogue no. 
NEBuffer 1 10 X NEB B7001S 
NEBuffer 2 10 X NEB B7002S 
NEBuffer 3 10 X NEB B7003S 
NEBuffer 4 10 X NEB B7004S 
 
6.6.3 DNA molecular size markers 
Tab. 8: Tabular overview of molecular DNA markers used within the present study.  
Name Size Company Catalogue no. 
Hyper ladder I 200-10000 bp Bioline Bio-33053 
Hyper ladder V 25-500 bp Bioline Bio-33057 
 
6.7 Consumables 
Tab. 9: Overview of expendable materials used within the present work.  
Consumable                                                                        Company 
Bacterial petri dish      TPP 
Cannulas (26 gauge)      Braun 
Cell culture flasks (25 cm2, 175 cm2, 300 cm2)  Nunc, TPP 
Cell culture plates (6 well, 24 well, 96 well)   Nunc, Corning 
Cell strainer 100 µm Nylon     BD Falcon 
Combi Tips (0,5 ml, 1,25 ml, 2 ml, 5 ml)   Eppendorf 
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Cryogenic vials      CytoOne 
Falcon Tubes (15 ml, 50 ml)     Greiner BioOne 
Gloves (nitrile, latex)                                                             Microflex 
Haematokrit capillaries (with heparin)   Schmidt 
LS columns       Miltenyi Biotec 
Lysing matrix D      MP Biomedicals 
PCR tubes (0,2 ml)      Biozym 
Perfusion needles (23G)  Ecoflo                                         Dispomed           
Pipette tips (10 µl, 20 µl, 200 µl, 1000 µl)   StarLab 
Reaction Tubes Safe lock (1,5 ml, 2 ml)   Sarstedt 
Syringes (1 ml, 2 ml, 5 ml, 10 ml, 20 ml, 50 ml)                   Omnifix 
Syringe filters (0,2 µm, 0,45 µm)                                          Sartorius 
Tissue culture dish                                                               Corning, Greiner 
Tissue culture flask (25 cm2, 75 cm2, 175 cm2, 300 cm2)     Nunc,TPP 
V-shape micro plate (96 well)      Nunc 
 
6.8 Software 
Tab. 10: Tabular overview of computer based analysis software.  
Name                                                                                   Company 
Adobe Photoshop (CS5)     Adobe Systems 
FACS Diva (v 5.0.2)                                                             BD 
FlowJo (v 10)       TreeStar Inc. 
GeneSpring       Agiland 
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GraphPad Prism (v 5)     Statcon 
LightCycler® 480 Software release 1.5.0                            Roche                                
Living Image (v3)      Caliper life sciences   
MS office (2010)      Microsoft 
 
6.9 Primer 
Tab. 11: Tabular overview of oligomer sequences as used during the study. Abbreviations: gt: genotyping; RT: 
realtime PCR.  
Name                         Sequence (5´-3´)             Application                                         Designed by
AgFusion1a  CAGGCACTCCTTTCAAGACC  RT-PCR
   
Dr. U. 
Hillebrand 
AgFusion2a  CCAAAAGACGGCAATATGGT  RT-PCR
   
Dr. U. 
Hillebrand 
AgFusion3a  GGAAAACTCGACGCAAGAAA  RT-PCR
   
Dr. U. 
Hillebrand 
AgFusion4a                GCGGTTGAGGACAAACTCTT          RT-PCR                       Dr. U. 
Hillebrand 
Cre1   GCCTGCATTACCGGTCGATGCAACGA   gt
   
Dr. U. 
Hillebrand 
Cre2   GTGGCAGATGGCGCGGCAACACCATT   gt
          
Dr. U. 
Hillebrand 
EMCVneo1  AAGAGTCAAATGGCTCTCCTCAAGCGTATT  gt
               
Dr. U. 
Hillebrand 
EMCVneo2  GTCTGTTGTGCCCAGTCATAGCCGAATAG    gt Dr. U. 
Hillebrand 
mAlbclifwd  GACAAGGAAAGCTGCCTGAC       RT-PCR C. Lipps 
mAlbclirev  TTCTGCAAAGTCAGCATTGG  RT-PCR C.Lipps 
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Ovafwd1  GCGCGCGTCGACACCATGGAATTTTGTTTTGATGT 
              cloning 
A. Ochel 
Ovarev1  GGATCCTTAAGGGGAAACACATCTGC  cloning A. Ochel 
Ovafl_RT_fwd 2         GGCATCAATGGCTTCTGA                  RT-PCR              A. Ochel 
Ovafl_RT_rev2           TCTCAAGCTGCTCAAGGC                  RT-PCR                   A. Ochel 
Ova sense   GTTTGAAAGTTGATAGGTC       cloning A. Ochel 
Ova as  TGAGAGTATAATCAACTTTG        cloning A. Ochel 
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6.10 Plasmids 
Tab. 12: Tabular overview of plasmids used within this work.  
Name Size Source  
pEMTARantiOvaAg 4465 bp Dr. U. Hillebrand (Sandhu et al., 2011) 
pCRTOPO2.1 3900 bp Invitrogen     
 
6.11 Cell lines 
Tab. 13: Overview of cell lines used within the present study.  
Name              Origin                                                      Source 
HEK 293 T  Large T antigen immortalized                   (Graham et al., 1977) 
  cell line from human embryonic kidney  
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6.12 Bacteria 
Tab. 14: List of bacterial strains used during the work for molecular applications. Competent bacterial strains were 
generated in house.  
Name 
Top 10                                                     chemically competent Escherichia coli 
XL-1 blue                                                    electro competent E. coli 
 
6.13 Viruses 
Tab. 15: Overview of viral strains used during the present work.  
Name Strain Source 
Adeno-Luc-GFP Type AdV5 (ΔE1) kindly provided by Dr. Werner 
Lindenmaier, HZI 
MCMV Luc  kindly provided by Prof. Luca 
Cicin-Sain, HZI 
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6.14 Mice 
All mice used were bred and maintained in the in house animal facilities of the Helmholtz 
Center for Infection Research. Mice were of the Black 6 background from Jackson 
laboratory, herein after referred to as BL/6, if wildtype mice are mentioned. Animals were 
bred and maintained under specific pathogen free (SPF) conditions in single ventilated 
cages. Further the mice received all nutrients ad libitum and had a controlled circadian 
rhythm of 12 hours. Animal experiments were performed in accordance to the german animal 
welfare law. The institutional guidelines have been approved by the local government of 
lower saxoney (permission: 33.14-42502-04-10/0199). 
Tab. 16: Overview of mouse strains used within this study. tg: transgenic 
Description Phenotype and source 
Ova ova is integrated in antisense orientation into the Rosa26 locus flanked by loxP 
sites (Sandhu et al., 2011) 
CreERT2 Cre recombinase fused to the tamoxifen dependent estrogen receptor is 
expressed under control of the serum albumin locus (Schuler et al., 2004) 
Ova x Cre Double transgenic animals for Ova and CreERT2, allowing tamoxifen 
dependent induction of the ova sense orientation exclusively in hepatocytes 
(Cebula et al., 2013; Sandhu et al., 2011). The model is based on heterozygous 
Ova-mice that carry the antisense orientated SWINFEKL encoding sequence of 
ovalbumin under control of the ubiquitously active rosa26 promoter. The 
transgene differs in one amino acid to the immunogenic wildtype protein of 
OvaSIINFEKL.  
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OT-I 
(Thy1.1) 
These mice are transgenic (tg) for CD8+ T cells which express the Vß5.1 chain 
for the SIINFEKL specific T cell receptor (TCR). According to thymic 
development the SIINFEKL specific α chain of the TCR develops leading to a full 
functional TCR that recognizes the Ova epitope SIINFEKL in context of MHC 
class I molecules. In addition the cells expressed the congenic marker Thy1.1 
(CD90.1) which allows backtracking upon adoptive transfers as Bl6/J express 
Thy1.2.  
OT-II  
(Thy1.1) 
These mice are transgenic for CD4+ T cells which express the Vß5.1chain for 
the ISQAVHAAHAEINEAGR specific TCR. OT-II mice were originally described 
in (Barnden et al., 1998). OT-II mice used within this study were kindly provided 
by Prof. Carlos A. Guzman. 
OT-II x 
Ova x 
Cre 
These triple transgenic animals were generated by mating OT-II tg mice to Ova x 
Cre double tg mice and allow the investigation of CD4+ T cell responses towards 
the auto antigen Ova.  
Bl6/J Black 6 inbred wildtype inbred strain. These mice were used for in vivo CTL 
experiments as donors to isolate antigen presenting cells from the spleen. 
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7. Methods 
7.1 Sterilization of equipment, media and solutions 
Buffers for gel electrophoresis and media were produced using autoclaved deionized water 
exclusively. All solutions, plastic consumables and surgical instruments were sterilized by 
autoclaving for 25 min. at 121°C. In case of heat sensitive components, solutions were 
sterilized by filtration using a filter with 0,2 µm pore size. Glassware was sterilized for 4 h at 
180°C in a cabinet drier. 
 
7.2 Molecular biological methods 
7.2.1 Work with nucleic acids 
Nucleic acids were stored at -20°C in TE-buffer or deionized H2O. RNA was stored in 
RNase free H2O (Qiagen) at -20°C.  
TE-buffer:     10 mM   Tris/ HCl (pH 7,6) 
       1 mM   EDTA 
 
7.2.1.1 Nucleic acid analysis  
Determination of DNA and RNA concentration 
For quantification of nucleic acids within an aqueous solution the extinction of such a solution 
was measured at a spectral photometer at a wavelength of 260 nm. The extinction value of 
an optical density (OD) of 1 is equivalent to a concentration of 50 µg dsDNA/ ml solution and 
40 µg ssRNA/ ml solution (Green, 2012). The purity of the solution was calculated by the 
ratios of extinction values against other wave lengths. The ratio of OD260/OD280 is an indicator 
for potential contaminations with proteins. The differences to the optimal value depicted in 
the literature display the grade of contamination. 
Literature value:      OD260/OD280=1,8 
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To determine the concentration of DNA/RNA, 1 µl solution was directly applied to a 
Nanodrop (Peqlab) and its extinction was measured. As nucleic acids were either dissolved 
in H2O or TE-buffer, the respective solvent was used as a blank control. 
 
7.2.1.2 DNA preparation  
Plasmids are extra chromosomal DNA elements with prokaryotic origin which are localized in 
the nucleoid in a supercoiled form. In addition they have specific sites for restriction enzymes 
and therefore allow genetic manipulation such as cloning of genes. Upon cloning of such 
constructs competent bacteria may be transformed with those which allow amplification of 
the gene of interest. By various DNA preparations the plasmids can be re-isolated from the 
bacterial cells. Isolation of plasmid DNA from liquid bacterial overnight (o.n.) cultures was 
dependent on the amount of needed DNA. 
 
7.2.1.3 Enzymatic modifications of DNA 
Digestion of DNA elements was performed using enzymatic kits (Tab. 6 and Tab. 7), 
according to manufacturer´s protocol. Those modifications allow the integration of PCR 
products into bacterial plasmids or the addition of reporter genes upstream or downstream of 
the gene of interest to detect the subcellular localization of a desired protein. 
Restriction of DNA fragments is based on the ability of restriction endonucleases to cut at 
specific target sequences within the molecule of interest. The treatment with such enzymes 
leads, depending on the enzyme used, to the generation of blunt or sticky ends within the 
molecule. 
The appropriate buffer, incubation time and temperature may vary and depend, on the one 
hand, on the amount of sequences accessible for the enzyme and on the other hand on the 
manufacturer´s guidelines. Generally, if not indicated otherwise, 2-3 units enzyme were used 
per µg DNA and incubated at 37°C for 3 h. 
In this study DNA restriction was used to create vectors for in vitro transcription of RNA 
encoding the antisense orientation of ova. In addition, restriction enzymes were used to 
verify the accuracy of DNA preparation from bacteria (test digestion). 
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7.2.1.4 Gel electrophoresis 
Gel electrophoresis is a biochemical assay which separates DNA fragments of different sizes 
within an electric field. Based on the negative charge of DNA, these fragments migrate to the 
electrode of opposed polarity. This allows the separation of DNA fragments according to their 
size only. This effect is due to the migration potential of molecules with different sizes as 
small molecules have a higher migration capacity than large molecules. 
This method of separation was used for analytical and preparative purposes. Analytical gels 
were performed to analyze PCR products and DNA fragments following restriction digests. 
Furthermore, they were done to proof the accuracy of in vitro transcription products. 
Preparative gels were performed to clone ova into the backbone the vector plasmid 
pCRTOPO2.1. In both cases agarose was used as gel matrix. 
 
Agarose gels 
Analytical agarose gels 
Agarose gels can be used as matrices to separate DNA molecules with a size of >100 bp 
(Southern, 1979). The accuracy of separation within those gels can be adjusted by varying 
the concentration of agarose (0.8 -2 % w/v). Agarose gels were produced by resuspension of 
the required amount of agarose in 1 x TAE buffer and subsequent heating of the solution. To 
visualize the DNA, Midori Green was added directly to the agarose solution. Upon 
polymerization of the gel matrix, 1 x TAE buffer was added to the chamber, the samples 
were diluted 1:5 with 6 x loading buffer and loaded onto the gel. For the analysis of PCR 
products amplified by use of Biomix (see chapter: 7.2.3.1 cloning and genotyping) the 
reaction was loaded onto the gel without prior application of loading buffer. To have a 
comparison of fragment size, 2,5 µl of a DNA molecular size standard were used and 
separated in a discrete lane. The standard used was dependent on the expected size of DNA 
fragments. For large fragments DNA Hyperladder I was used, for small molecules DNA 
Hyperladder V (see Tab. 8).The amperage provided was dependent on the concentration of 
the gel matrix. For gels with a concentration of ≥0,8% (w/v) 100-120 V were provided. The 
documentation and visualization of DNA fragments were performed using a UV-trans 
illuminator equipped with a camera system. 
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Preparative agarose gels 
Preparative gels were performed to isolate specific fragments from a mixture of fragments, 
e.g. if specific fragments of DNA were required after restriction digestions. Following 
separation of DNA fragments within the agarose matrix, the fragment of interest was 
detected using a trans illuminator and cut out of the agarose gel using a sterile scalpel. The 
extraction of the DNA within the desired band was conducted using a complete kit (QIAquick 
Gel extraction Kit, Qiagen) according to manufacturer´s protocol. The extracted band was 
then eluted in 20 µl ddH2O instead of TE-buffer. In contrast to analytical gels, in which only 
small amounts of DNA are separated, in preparative gels the total volume of the desired 
reaction was used. This ensures a maximum yield of DNA for further steps. 
 
50 x TAE buffer     2 M Tris/ HCl (pH 8.0) 
                 50 mM EDTA 
                 adjust pH 8,0 using glacial acetic acid 
6 x Gel loading buffer      40% (w/v) Ficoll 
       0,05% (w/v) Brominephenolblue 
       0,05% (w/v) Xylencyanol 
 
7.2.1.5 Ligation 
Ligations are reactions in which 5´phosphate groups and 3´hydroxygroups of dsDNA 
molecules are covalently linked generating continuous DNA strands. This reaction requires 
ATP to catalyze these phospho diester linkages. Ligations were performed in order to clone 
restriction fragments into plasmid backbones. 
Assay       Vector backbone  1 µl 
       Insert   7 µl 
       10 X Ligase buffer 2 µl 
       T4 DNA ligase 1 µl 
       ad H2O            20 µl 
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The ligation mixture was incubated o.n. at 16°C and subsequently transformed into electro 
competent bacteria (XL-1 blue) as described in chapter: 7.3.3 Transformation of competent 
bacteria. The DNA was isolated the next day using a mini preparation (see chapter: 7.2.1.6 
DNA purification). 
 
7.2.1.6 DNA purification 
In order to obtain plasmid DNA for molecular biological techniques as well as the desired 
DNA construct after cloning, DNA was purified from bacteria according to the protocol 
described below. Further, chromosomal DNA was isolated from eukaryotic tissue for 
genotyping of transgenic mice.  
DNA small scale isolation (mini preparation) 
To extract plasmid DNA from bacteria, 2 ml LB medium supplemented with 50 µg/ml of the 
required antibiotic were inoculated with the respective E. coli clone and cultured o.n at 37°C 
while shaking at <600 rpm. The next day these o.n. cultures were transferred to a 
centrifugation tube and centrifuged for 1 min. at 13000 rpm. The supernatant was discarded 
and the pellet resuspended in 500 µl STET-buffer by thorough vortexing. 50 µl lysozyme/TE 
(10 mg/ml) were added to lyse the bacterial cell wall and the reaction mixture was incubated 
at room temperature (RT) for 2 to 3 min.  To inactivate the lysozyme, the assay was heated 
for 2 min at 95°C and centrifuged for 5 min. at 13000 rpm. The resulting pellet was removed, 
using an autoclaved tooth picker, 50 µl 8 M NH4Ac as well as 500 µl isopropanol were added 
to the supernatant containing the DNA. The suspension was centrifuged at 13000 rpm for 5 
min. to precipitate the DNA. The supernatant was discarded and the DNA pellet air dried at 
RT. Afterwards, the DNA pellet was resuspended in 50 to 100 µl TE-buffer, supplemented 
with RNase and incubated at 37°C until the DNA was completely dissolved. 5 µl of purified 
DNA were used for a test restriction to verify the correct plasmid DNA (see chapter: 7.2.1.3 
Enzymatic modifications of DNA). 
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STET-buffer    Sucrose    80 g/l 
Triton X 100    0,5% 
EDTA     50 mM 
Tris/HCl    10 mM 
Adjust pH 8,0 
Lysozyme    Lysozyme in TE buffer  10 mg/ml 
TE RNase    RNase A in TE buffer   10 µg/ml 
           
 
7.2.2 Work with RNA 
The expression of a gene is mediated by binding of the RNA polymerase II (RNA Pol II) to 
the promoter region of a given gene. The RNA Pol II drives along the ORF of this gene, 
copies its nucleotide sequence and thereby processes a transcript called, messenger RNA 
(mRNA) until it reaches a stop codon which leads to termination. The mRNA is further 
processed and then released into the cytoplasm where its sequence can be translated into a 
polypeptide. The presence and abundance of mRNA´s within a cell can give knowledge 
about the expression status and quantity of a specific gene and thus, it is an indirect proof, if 
a gene is expressed under specific conditions on a cellular level. The presence of transcripts 
from a specific gene can be shown by marking them specifically. Further, the amount of RNA 
molecules from a specific gene allows quantifying the strength of gene expression. This can 
be done by qRT-PCR as well as whole mount in situ hybridization (WISH). 
 
7.2.2.1 RNA purification and storage 
Within this study, the purification of RNA was performed using the RNeasy kit from Qiagen 
according to the manufacturer´s instructions. The purified RNA was eluted in 30–50 µl 
RNase-free H2O. To avoid contamination with DNA, an on-column DNaseI I digestion was 
performed during the purification. In case very low amounts of cells were used, the RNA was 
isolated by use of the RNAmicro kit from Qiagen, in this case the RNA was eluted in 14 µl 
RNase-free H2O. All RNA samples were stored at -20°C for short-term use. For long-term 
storage the samples were kept at -70°C. 
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RNA isolation upon in vitro transcription 
The purification of in vitro transcribed RNA was performed using the RNeasy kit from Qiagen. 
Upon in vitro transcription RNA was purified and subsequently used for whole mount RNA in 
situ hybridization (WISH). The in vitro transcription mix was filled with RNase-free H2O to a 
total volume of 100 µl. Then, 350 µl RLT and 250 µl EtOH (100%) were added to the mixture 
and the whole suspension was transferred to an RNeasy Spin column. Following 
centrifugation at 13000 rpm for 1 min., the flow through was discarded. The column was 
washed twice with 500 µl RPE buffer and centrifuged at 13000 rpm for 1 min. for each step. 
To dry the column, it was centrifuged for 5 min. at 13000 rpm and then transferred to a new, 
RNase-free centrifugation tube. 50 µl RNase-free H2O were directly added to the center of 
the column and incubated for 2 min. followed by elution of the bound DNA by centrifugation 
at 13000 rpm for 1 min. The purified RNA was stored at -20°C. 
RNA isolation from liver tissue 
RNA was isolated from murine liver tissue to subsequently generate complementary DNA 
(cDNA). This cDNA was used in qRT-PCR to determine the amount of antigen expression 
within the liver of Ova x Cre mice. 
Liver tissue was stored at -70°C and thawn on ice directly before RNA isolation. The sample 
was transferred to a FastPrep tube (Lysing matrix D, MP Biomedicals) containing 600 µl RLT 
buffer supplemented with 1/10 ß-ME. The whole tissue was homogenized 3 times for 20 sec. 
in a tissue homogenizer. Afterwards the RNA was purified using the RNeasy kit (Qiagen): 
The disrupted tissue was centrifuged at 13000 rpm for 3 min. and the supernatant transferred 
to another tube containing 1 volume 50% ethanol. The sample was mixed and then, a 
maximum volume of 700 µl was loaded to an RNeasy column (Qiagen). The column was 
centrifuged for 15 sec. at 13000 rpm and the flow through was discarded. The remaining 
cell extract/ethanol was loaded onto the column and centrifuged as described above. The 
column was washed once using 350 µl RW1 buffer by centrifugation at 13000 rpm for 15 sec. 
To remove remaining DNA, 10 µl DNaseI I (Qiagen) were diluted in 70 µl RDD buffer and 
added directly to the center of the column. The column was incubated for 15 min. at RT and 
washed again with 350 µl RW1 buffer (13000 rpm, 15 sec.). Afterwards the column was 
washed twice with 500 µl RPE buffer and centrifuged at 13000 rpm for 15 sec. or 2 min. in 
the last washing step. Afterwards the column was placed to a new centrifugation tube and 
centrifuged for 1 additional minute to remove remaining RPE buffer. Upon this centrifugation 
the RNA eluted in 30 µl RNase-free H2O by spinning the tube for 1 min. at 13000 rpm. To 
increase the RNA yield, the eluate was loaded onto the column again and centrifuged at 
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13000 rpm for 1 min. 1 µl of the eluate was used to determine the concentration using the 
Nanodrop (see chapter: 7.2.1.1 Nucleic acid analysis). The residual sample was stored 
at -20°C until it was further processed. 
 
7.2.2.2 RNA in vitro transcription and in situ hybridization 
RNA in situ hybridization is a method by which an antisense probe is introduced into 
previously fixed cells. As the probe against an mRNA molecule is in antisense orientation, it 
binds to the specific mRNA molecule, creating a dsRNA hybrid. This dsRNA hybrid in turn 
can be visualized as the probe is labeled either with an antigen, recognized by an antibody, 
or radioactively (Almeida Engler et al., 1994). 
RNA in situ hybridization was used to analyze the percentage of ova expressing hepatocytes 
in the Ova x Cre mouse model. The used RNA probes were labeled with Digoxigenin (DIG) 
during in vitro transcription using a DIG-labeling kit, kindly provided by Prof. Reinhard Köster 
(Technical University Braunschweig). 
Assay 
Linearized template DNA (PCR Topo 2.1_Ova cut with BamHI)  10 µg 
10 x Transcription buffer       3 µl 
10 x DIG buffer        3 µl 
T 7 RNA polymerase        1 µl 
RNasin         1 µl 
H2O              ad 29 µl 
 
The assay was incubated at 37°C for 1 h. Afterwards 1 µl of T-7 polymerase was added to 
the mixture once more and incubated for an-other hour. Upon incubation, 1,5 µl DNaseI I 
were added to the reaction and incubated for 20 min. at 37°C to degrade the remaining DNA 
template. Upon the DNaseI I digestion, the RNA was purified as described below (see 
chapter: 7.2.2.1 RNA purification and storage). 
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7.2.2.3 cDNA synthesis 
The discovery of the viral enzyme reverse transcriptase (RT) (Baltimore, 1970) was initially 
contradictory to the central dogma of molecular biology, which so far assumed that the 
transfer of gene information from DNA via mRNA to a polypeptide is unidirectional 
(Orphanides & Reinberg, 2002). Yet, nowadays reverse transcription provides various 
analytical possibilities within molecular biology. 
RT is an RNA dependent DNA polymerase that synthesizes a complementary DNA molecule 
(cDNA) based on an RNA template. The reaction is mediated by initial binding of a primer to 
the 3´-OH group of an RNA molecule which is then elongated by the RT, creating a 
dsRNA/DNA hybrid. After degradation of the RNA template strand, a dsDNA molecule is 
synthesized according to the sequence of the cDNA (Keller & Crouch, 1972). 
Using this method, the abundance and frequency of an mRNA can be investigated by qRT-
PCR (see chapter: 7.2.3.3 Quantitative Realtime PCR (qRT-PCR)). The cDNA synthesis can 
be performed in two ways. Either by using a specific primer, which only produces cDNA from 
a specific mRNA molecule, or by use of an oligo-dT primer that unspecifically binds to the 
poly A tail of mRNA. Thus, a cDNA is synthesized from every mRNA template that is present. 
Upon the RT reaction cDNA can be used directly for PCR without further purification or 
modification. 
For quantitative RT-PCR, isolated RNA was adjusted to a concentration of 100 ng/µl and 
dissolved into 30 µl RNase-free H2O. The cDNA synthesis was performed using the Ready to 
go you prime 1st kit (GE Healthcare) according to manufacturer´s protocol. cDNA was stored 
at -20°C. 
 
7.2.3 Polymerase chain reaction (PCR) 
The PCR was developed in 1987 by Kary B. Mullis and is a method which allows to 
specifically amplify a DNA fragment of interest in vitro (Mullis & Faloona, 1987). The yield will 
give a high amount of amplicons, as the reaction leads to exponentially reactions of 
polymerization. The PCR is based on three general components: 1. a double stranded DNA 
dependent DNA polymerase, which catalyzes the amplification of DNA. As the fragment of 
interest that has to be amplified is ds, the DNA has to be denatured at high temperature prior 
to amplification, and therefore, a heat-stable DNA polymerase (Taq from Thermus aquaticus) 
was used. 2. a DNA fragment which is used as a template for amplification. 3. a primer pair 
flanking the region of interest. The primers are complementary to the sequence that has to 
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be amplified. Upon hybridizing to the template, primers are recognized by the polymerase. 
To mediate the amplification the primer has to have a free hydroxygroup at the 3´end. The 
polymerase binds to this hydroxygroup and starts to catalyze amplification of DNA in 
direction of the 3´end, a process called elongation. 
The PCR´s are cyclic reactions. Each cycle is temperature dependent and divided into three 
steps, called denaturation, annealing and elongation. Denaturation of the template, in which 
the hydrogen bonds between the DNA strands are cleaved, is performed at 94°C. The 
temperature of this reaction depends on the GC-content of the template as these base pairs 
are bridged to each other by three hydrogen bonds. Annealing is the hybridization of the 
complementary primer to the single DNA strand and is performed at temperatures between 
45°C to 65°C. The last reaction is the elongation in which the primer is extended and the new 
dsDNA synthesized. This step is done at 72°C which is the optimal temperature of the Taq 
DNA polymerase. 
All primers used were designed using the online tool PRIMER3. The design was performed 
with respect to an optimal length of 17-18 nucleotides in the area of hybridization and a GC 
content between 50 to 60%. The required melting temperature of primers was between 55°C 
to 60°C. The forward and reverse primer should not share any complementary region to each 
other to avoid primer hybridization. 
The amount of cycles varied depending on the experiment performed. For cloning and 
genotyping, 31 cycles were done, for realtime PCR 45 cycles were performed. 
In this work PCR was used to generate PCR products which were cloned into targeting 
vectors or to verify the genotype of the used transgenic mice. Realtime PCR was performed 
to detect the amount of ovalbumin expressed in murine hepatocytes and to confirm antigen 
clearance. 
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7.2.3.1 Cloning and genotyping 
Genotyping assay 
Biomix    15 µl 
fwd primer  2,5 µl 
rev primer  2,5 µl 
mouse tail DNA    2 µl 
ad H2O   30 µl  
 
Amplification reactions for cloning 
Template (10 ng/ µl)   
10 x reaction buffer  5 µl 
DMSO    1 µl 
fwd primer (10 pmol)  5 µl 
rev primer (10 pmol)  5 µl 
dNTP mix (25 mM)  8 µl 
Polymerase         0,75 µl 
ad H2O            50 µl 
 
The PCR cycles in genotyping and cloning reactions were similar and were performed as 
described as follows.  
Methods 
107 
 
1. 95°C   5 min.  initial denaturation 
2. 72°C   10 min.  
3. 94°C    30 sec. denaturation 
4. 58°C   45 sec. annealing 
5. 72°C   90 sec. elongation go to step 2, 29 cycles 
6. 72°C   10 min. final elongation 
7. 16°C   hold 
 
7.2.3.3 Quantitative Realtime PCR (qRT-PCR) 
qRT-PCR allows the exact quantification of target nucleic acids. This is achieved by the 
addition of fluorescent dyes that bind into the minor groove of dsDNA molecules. As the 
fluorescent intensity increases proportional to the amount of generated PCR product within 
each cycle, it enables to conclude the amount of initial target RNA. In contrast to RNA in situ 
hybridization, which allows the analysis of gene expression pattern on a cellular level, 
qRT-PCR specifically detects the total amount of target sequence. Within qRT-PCR one 
discriminates between absolute and relative quantification. The absolute quantification 
determines the actual amount of a target sequence. This amount can be depicted as copy 
number or concentration. In contrast, the relative quantification enables a numerical 
estimation of a target molecule, compared to a reference gene. A so called housekeeping 
gene served as reference gene as its expression is not changed, despite different 
experimental conditions. The calculated ratio of target molecule vs. housekeeping gene can 
be compared to the ratio of other samples which allows the analysis of changes in the gene 
expression pattern under different experimental approaches. 
In this work relative qRT-PCR was used to determine the expression pattern of ova within the 
hepatocytes of Ova x Cre mice upon Tamoxifen treatment, compared to non-treated 
Ova x Cre mice. The expression of ova was always compared to the hepatocyte specific 
gene albumin. Furthermore, qRT-PCR was performed to detect the clearance of Ova 
presenting hepatocytes. 
cDNA generated during cDNA synthesis (see chapter7.2.2.3 cDNA synthesis) was diluted in 
nuclease free H2O in a 1:10 ratio. The reaction was performed in the LightCyler
® 480 (Roche) 
using a special 96 well plate (Roche). The qRT PCR for each sample was performed in 
triplicates. 
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Assay 
cDNA (1:10)          5 µl 
fwd primer       2,5 µl 
rev primer       2,5 µl 
SybrGreen        10 µl 
 
A mastermix consisting of SybrGreen, fwd and rev primer was prepared and given into a 
96-well. To relate the gene expression of each target gene, each sample was investigated 
separately, performing a qRT-PCR against a housekeeping gene. The plate was centrifuged 
for 1 min. at 1000 rpm to allow the mastermix to settle at the bottom of the well and 5 µl of 
the previously diluted cDNA were added to the respective well. 
The reaction was performed according to the following conditions in the light cycler 
1. Pre incubation   95°C  15 min. 
2. Amplification     
a. Denaturation   95°C  15 sec. 
b. Annealing   58°C  20 sec. 
c. Elongation   72°C  30 sec. 
3. Melting curve     
a.                                               95°C  5 sec. 
b.                                               70°C  1 min. 
c.                                               95°C  continuously 
4. Cooling    40°C  30 sec. 
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7.3 Work with bacteria 
7.3.1 Cultivation and storage 
The bacteria listed in Tab. 14 were cultivated either in LB medium or on LB agar plates at 
37°C in the presence of antibiotics. In general bacteria can be stored for up to 8 weeks on 
agar plates at 4°C. For long-term storage a bacterial liquid culture was added to the 
appropriate amount of sterile 50 % glycerol and the bacterial stocks were stored at -70°C. 
LB- medium:    10 g/l  Bacto Trypton 
       5 g/l   Yeast extract 
     10 g/l  NaCl 
     Autoclaved 
Agar plates:    10 g/l  Bacto Trypton 
       5 g/l  Yeast extract 
     10 g/l  NaCl 
     15 g/l  Agar 
     autoclaved 
Autoclaved, cooled down to 50°C, supplemented with antibiotics and added to petri dishes. 
Stored in the dark at 4°C. 
 
7.3.2 Generation of competent bacteria 
The competence of bacterial cells is achieved by previous treatment of those with calcium or 
other bipolar ions. These molecules permeabilize the cellular membrane an thereby allow an 
incorporation of exogenous substances (Mandel & Higa, 1970). Competent bacteria were 
shock frozen in liquid nitrogen and stored at -80°C until they were used for transformation 
experiments. 
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7.3.3 Transformation of competent bacteria 
Transformation is the transfer of plasmid DNA into competent bacteria to allow the 
amplification of vectors (plasmid DNA). 
For plasmid amplification, 1 µl of the desired vector DNA were added to 50 µl competent 
bacteria (Tab. 14) and incubated on ice for 5 min. Afterwards, the cells were incubated at 
37°C for 10 min. and then chilled on ice for 90 sec. Following heat shock, 1 ml LB media was 
added to the bacterial cells and the suspension was incubated for 30 min. at 37°C. Following 
this incubation period, 10 µl and 1 ml of the bacterial suspension were platted on a selection 
agar plate, respectively and incubated over night at 37°C. On the following day colonies were 
picked to inoculate liquid cultures for DNA purification (see chapter: 7.2.1.6 DNA purification 
DNA small scale isolation (mini preparation)) and restriction analysis to verify the accuracy of 
the DNA. 
Following ligations, the transformation of competent bacteria was done as described above. 
In contrast, instead of 1 µl of plasmid DNA, the whole ligation volume (20 µl) was added to 
the competent cells. 
Electro competent bacteria (XL-1 blue) were thawn on ice in a 1.5 ml reaction tube. 1 µl 
vector that had to be amplified, or complete ligation reactions were given to the cells and 
stored on ice. Liquid droplets were removed from the outer side of the cuvette and the 
bacteria with vector were transferred into it. The cuvette was placed into the chamber and 
pulsed with 25 µF capacity/200 ohm. The bacteria were electroporated for 4,4 s at 2,5 kV. 
Subsequently they were transferred into a reaction tube supplied with 1 ml LB medium and 
kept for 30 min. at 37°C. Afterwards the cells were plated on selection agar as described 
above. 
 
7.4 Work with viruses 
For the work with viruses only sterile plastic pipettes and filter tips were used. Work was 
performed under sterile S2 conditions. 
 
7.4.1 Cultivation of low passage HEK 293T cells 
HEK 293T cells were cultivated in cell culture flasks in MEM/5% FCS at 37°C in the presence 
of 95% humidity, 5% CO2. Initially, cells were cultured in 25 cm
2 flasks. When the cells 
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reached a confluence of 80-90%, cells were expanded to larger flasks (175 cm2 and finally 
300 cm2). For expansion, the medium was removed and cells were gently washed in PBS. 
Upon removal of PBS, cells were detached by adding the appropriate volume of trypsin to 
the cells. Cells were incubated in presence of trypsin at RT until detaching was visible under 
the microscope. Trypsin was stopped by adding MEM/5% FCS to the suspension. The 
suspension was gently resuspended and cells were transferred to fresh medium in a ratio of 
1:10/flask. 
 
7.4.2 Adenoviral production 
HEK293T (passage <40) cells were cultured in MEM/ 5% FCS on Rx300 flasks till 
confluence. The media was removed and cells were infected with diluted adenovirus (1:9 in 
PBS/2% FCS). The infection assay was performed for 1 h at RT on a shaker. Afterwards 70 
ml media was supplied to the cells. Infection was continued for 2 days at 37°C/95% 
humidity/5% CO2. 
 
7.4.3 Cell harvesting and virus purification 
The infected cells were harvested from an Rx300 flask by using a cell scraper and 
subsequently transferred to 50 ml falcon tubes. Falcon tubes were centrifuged at 1500 rpm 
for 10 min. at 4°C and supernatants were discarded. Cell pellets from different flasks were 
pooled and finally taken up in 45 ml Tris-buffer (pH 8, 4°C). Cells were centrifuged (1500 
rpm, for 10 min. at 4°C) and lysed by 3 freeze-thaw cycles. The resulting lysate was 
supplemented with 1/10 volume of Na-desoxycholate (5%) and incubated for 30 min. on ice. 
Afterwards, 1-2 µl benzonase were added to the lysate and incubated for 30-90 min. at RT. 
Sedimentation of cell debris was achieved by centrifugation for 10 min. 2500 rpm at 4°C. The 
resulting supernatant (containing viral particles) was removed and the sediment was frozen 
for possible re-isolaion of virus. The supernatant was refilled with Tris-buffer (0,1 M; pH 8) to 
exactly 3,1 ml. Furthermore, 1,8 ml saturated CsCl solution was added to the supernatant 
and mixed gently. The solution was transferred to an ultra-centrifugation tube. The tube was 
placed into an ultracentrifuge and gradients were centrifuged at 47000 rpm for 20 h. The 
band which corresponds to the virus was removed using a syringe and purified a second 
time using a CsCl gradient for 20 h. Afterwards, the volume of the virus containing solution 
was determined using a microliter pipette and the virus titrated. 
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7.4.4 Adenoviral infection of mice 
Adenovirus was demonstrated to have hepatotropic capabilities (Huang et al., 2012; 
Stabenow et al., 2010) but does not replicate within hepatocytes if the E1 encoding region is 
deleted. To generate an endogenous immune response against Ova within the mice, 
adenoviral infection was performed coincidental to Tam driven induction of Ova expression. 
Per mouse 1 x 1010 pfu Adeno-Luc-GFP (6.13 Viruses) were administered intravenously (i.v.) 
similar as described for adoptive transfers. To achieve hepatocyte specific expression of Ova 
coincidental to infection, mice were treated with Tam on day -1 and 0 and infection was 
performed on day 0. To track the route of infection, in vivo bioluminescence imaging (7.5.1.2 
In vivo bioluminescence imaging) was performed on several time points relative to infection. 
 
7.5 Work with mice 
7.5.1 Application methods 
7.5.1.1 Tamoxifen administration to mice 
Tamoxifen was administered orally to the mice by a gavage, using a special feeding needle 
(Heiland Vet GmbH). To prepare a total concentration of 50 µg or 1 mg/ 400 µl, a Tamoxifen 
tablet (10 mg, Ratiopharm) was crushed into fine powder using a mortar and pestle. The 
powder was transferred into a falcon tube and supplied with 2 ml ClinOleic infusion solution, 
to get a stock concentration of 5 mg/ml. This stock solution was rotated at 4°C for at least 
4 h. Afterwards the solution was diluted in ClinOleic (Baxter) to a final concentration of either 
50 µg, 1 mg or 8 mg/400 µl and given to the mice. A single dose of 50 µg Tam turned out to 
be sufficient for the induction of ova sense orientation. 
 
7.5.1.2 In vivo bioluminescence imaging 
In vivo bioluminescence imaging is a powerful non-invasive tool to analyze in vivo kinetics 
without prior euthanization of experimental animals. In this work in vivo measurement of 
bioluminescence was used to determine the site of viral tissue tropism upon infection of mice 
with viruses, expressing the reporter gene luciferase (Tab. 15) using the Xenogen IVIS 200 
system (Caliper Life Sciences). This system allows the detection of low light levels and is 
optimized for in vivo imaging (whole animal studies). Photons produced in the subject diffuse 
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through the tissues, the means of excitation at the surface of the imaged subject are 
captured by a sensitive photon charged-coupled device (CCD) camera. 
For analysis of mice with this technique, the mice were first anaesthetized in a special 
chamber (Caliper Life Sciences) which provides 2-2,5% Isofluran (Allbrecht). Once the mice 
were anaesthetized, 100 µl luciferin (30 mg/ml in PBS, Synchem OHG) were administered 
intraperitoneally (i.p.). Afterwards, the mice were placed into the acquisition chamber 
immediately, as well providing 2-2.5% Isoflurane. To allow a systemic diffusion of the injected 
substrate, the measurement was started 4 min. after luciferin injection. To acquire the 
bioluminescent images, several parameters have to be adjusted to control the sensitivity and 
resolution of the signal: 
 Field of view: depends on the distance between subject and camera lens 
 Exposure time: the collection of  emitted light is  directly proportional to the 
amount of time the camera shutter is open 
 Aperature (f/stop): controls the amount of light collected 
 Binning: refers to the CCD resolution 
 
7.5.1.3 Intravenous application 
Intravenous (i.v.) application was always performed to administer viruses, pure CD8+ T cells 
or total splenocytes to recipient mice. Recipient mice were exposed to red light, to induce 
dilatation of the veins for ~4 min. prior to application. Mice were fixed within a restrainer and 
substrates were injected into the tail vein by a 26 gauge syringe (Braun) in the indicated 
volume (see chapters: 7.4.4 Adenoviral infection of mice, 7.7.3 In vivo cytotoxic T lymphocyte 
(CTL) assay and 7.7.4 Magnetic isolation of splenocytes). 
 
7.5.1.4 Blood sampling and alanine amino transferase (ALT) measurement 
Blood sampling was performed to indicate the liver function by measurement of serum ALT 
levels. Mice were anaesthetized by Isoflurane and blood was taken by retro-orbital bleeding, 
using a heparin coated capillary. Blood samples were added to 25 µl heparin (1,25 I.E, 
Ratiopharm) to avoid clotting. Samples were centrifuged at 13000 rpm for 5 min. and 32 µl 
plasma were loaded to a test strip (Roche Diagnostics, Mannheim) to measure the ALT 
concentration on a Reflovet®Plus reader (Roche Diagnostics, Mannheim). 
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7.6 Flow cytometry 
A flow cytometer is a physical device that enables the investigation and examination of small 
particles, as for example cells. The method is based on a stream of fluid containing 
suspended cells. This stream creates a laminar flow and passes through a light beam, where 
an electronically detection apparatus is provided within the device itself. According to the 
laminar flow, cells pass the detector one by one (Brown & Wittwer, 2000). The apparatus 
enables both, detection and discrimination of cells according to their size and morphology. 
One detector is in line with the light beam and measures the size of passing particles 
(forward scatter (FSC)). Another detector is aligned perpendicularly to the FSC-detector and 
measures the granularity of passing cells (side scatter (SSC)) (Jin et al., 2007). Since every 
cell type has a specific size and granularity, the correlation of FSC vs. SSC allows the 
discrimination of specific cells within a heterogeneous population. By adjusting the voltage 
during acquisition the resolution can be increased or decreased to visualize the target cells. 
Flow cytometry allows simultaneous investigation of multiple parameters. Apart from 
discriminating different cell populations, phenotypic variations within one population can be 
investigated on <2000/ sec. (Brown & Wittwer, 2000). This is mediated by fluorescent dyes 
that can be applied to cell cultures or fluorescent dyes that are conjugated to specific 
antibodies. Antibodies bind to target epitopes present on the cells of interest and thus label 
the cells specifically. Since flow cytometers are provided with different lasers and filters, the 
cells are excited to emit light of a specific wavelength while passing the detection apparatus. 
The fluorescent dye emits a longer wavelength which can be detected by the filter (Brown & 
Wittwer, 2000). For each fluorescent emission peak, one filter is provided. By this 
combination characteristics of individual cells can be quantified. 
In addition to phenotypic analysis, specific cell sorters are present which allow extrapolation 
of the cells of interest from a heterogeneous cell population. The principle is similar as 
described above and is also performed by surface staining. However, it has to be considered 
for which purposes sorted cells are required and which phenotype the cells should display 
upon sorting. If for example markers that induce cell activation are used during the sorting, 
the resulting cell fraction is not naïve any more. 
Flow cytometry was used within this work to investigate the phenotype of leucocytes from 
various murine tissues upon immune responses. Moreover, cells were often analyzed for the 
expression of different markers prior to adoptive transfer experiments to investigate the 
phenotype of transplanted cells. For cellular acquisition the flow cytometer LSR II (BD) was 
used. Since multiple color stainings were performed, aliquots of cells were stained 
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individually with every dye used in the respective protocol to enable compensation. This is 
required to avoid cross emissions by different dyes that might lead to false positive signals 
within the multi-color stained samples. 
  
7.7 Eukaryotic cell culture 
For the work with eukaryotic cells only sterile pipettes, buffer, media, bottles and tubes were 
used. Work was done under sterile conditions using clean benches. 
 
7.7.1 Isolation of immune cells from murine tissue 
Mice were euthanized prior to cell isolation from any tissue. If the blood system had to be 
accessible, the mice were euthanized by an overdose of Isoflurane (Allbrecht GmbH). In 
case only specific tissues, e.g. spleens, were of interest, the euthanization could be 
performed by decapitation. Work was done under sterile conditions, using autoclaved 
surgical tools. 
 
7.7.1.1 Isolation of primary murine lymphocytes from liver draining lymph nodes 
The abdomen of previously euthanized mice was opened and the celiac lymph node (cLN) 
located close to the vena cava was isolated by using a small forceps. Afterwards, the cLN 
was transferred to a 100 µm cell strainer which was placed into a six well dish. 2-3 ml 
PBS/1% FCS were added to each well and the cLN was smashed through the cell strainer 
using a piston. The piston and cell strainer were washed twice with 1 ml PBS/1% FCS and 
the suspension transferred to a 15 ml falcon tube. After centrifugation, at 1500 rpm for 5 
min., the supernatant was discarded and the cells resuspended in 1 ml PBS/1% FCS. 
Afterwards, the cells could be used for staining (see chapters: 7.7.5 Staining protocols for 
flow cytometry, 7.7.5.1 Surface staining of lymphocytes and 7.7.5.3 Intracellular FoxP3 
staining). 
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7.7.1.2 Isolation of primary murine lymphocytes from the spleen 
Splenic located lymphocytes were isolated for phenotyping of CD8+ T cells in final 
experiments. Alternatively, lymphocytes were isolated from spleens of BL/6 or OT-I mice if 
required for adoptive transfer experiments. 
Mice were euthanized with an overdose of Isofluran (for T cell phenotyping) or decapitation 
(for adoptive transfer experiments). Using sterile scissors the left flank of the mice was 
opened and the spleen isolated. The spleen was transferred into 10 ml PBS/1% FCS and 
minced through a previously boiled steel sieve using a 5 ml syringe. The suspension was 
transferred into a 15 ml centrifugation tube and pelleted at 1500 rpm for 5 min. The 
supernatant was discarded and the pellet resuspended in 10 ml erythrocyte lysis buffer. The 
cells were incubated for 5 min. at room temperature and centrifuged again at 1500 rpm for 5 
min. Following centrifugation, the pellet was washed twice in 10 ml PBS/1% FCS. Upon the 
last washing step, the suspension was transferred onto a cell strainer (100 µm) which was 
placed in a 50 ml falcon tube to remove fatty debris. For T cell phenotyping, the isolated 
splenocytes, containing lymphocytes were directly used for counting (see chapters: 7.7.2 
Counting of isolated primary lymphocytes) or specific stainings (see chapters: 7.7.5 Staining 
protocols for flow cytometry, 7.7.5.1 Surface staining of lymphocytes and 7.7.5.3 Intracellular 
FoxP3 staining). 
 
7.7.1.3 Isolation of primary murine lymphocytes from the liver  
Upon finalizing an experiment, intrahepatic lymphocytes were isolated for phenotyping or 
RNA-sequencing analysis. 
Mice were euthanized by applying an overdose of Isoflurane. Decapitation is not possible for 
this procedure, as the blood system needs to stay intact. Euthanized mice were fixed and the 
abdomen was opened. If blood samples for ALT or cytokine profiling were required, 
approximately 200 µl blood were taken from the vena cava or the heart and mixed with 25 µl 
heparin (1,25 I.E). A sterile butterfly needle was inserted into the vena cava and the liver was 
perfused with a total volume of 10 ml liver perfusion medium. During the perfusion, the portal 
vein was cut to enable blood flow. In case liver tissue had to be sampled for RNA-isolation 
(see chapter: 7.2.2.1 RNA isolation from liver tissue), small pieces of the liver were isolated 
during the perfusion procedure, transferred to a cryo vial which was directly stored in liquid 
nitrogen. For long-term storage, samples were always kept at -70°C. Upon perfusion, 
another syringe, containing liver digest medium, was connected to the butterfly needle and a 
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total volume of 5 ml was injected into the mouse. This enables in situ pre-digestion of the 
liver. Eventually, the gall bladder was removed and the whole liver transferred to a 50 ml 
falcon tube containing 10 ml liver digest medium. Following digestion of the liver, pieces of 
liver tissue were incubated in liver digest medium for 30 min. at 37°C which allows complete 
digestion of the tissue. Afterwards, the tissue was minced through a cell strainer by using a 
piston. The cell suspension was transferred to a 50 ml falcon tube (labeled with `A`) and filled 
with PBS to a total volume of 45 ml. To separate the hepatocytes from the non-parenchymal 
cells (NPC) which were the cells of interest, the samples were centrifuged at 500 rpm for 5 
min. This allows pelleting of the hepatocytes, whereas the NPC fraction remains within the 
supernatant. The supernatant was transferred to a new 50 ml falcon (labeled `NPC`) and 
centrifuged again at 1500 rpm for 5 min. In addition, the hepatocyte pellet (in tube `A`) was 
filled with PBS to a total volume of 45 ml and centrifuged as described before. The 
supernatant in the tube labeled NPC was discarded. After the second fractionation of tube 
`A`, the NPC fraction from tube `A` was transferred to the pelleted NPC fraction from the first 
centrifugation. The NPC were centrifuged again at 1500 rpm for 5 min. The supernatant was 
discarded and the pellet resuspended in 3ml PBS/1% FCS. Then, 3,5 ml of a 70% percoll 
solution were added to the sample and the NPC cells were resuspended. Afterwards the cell 
suspension was gently overlaid on 70% percoll in a 15 ml falcon tube, creating a gradient. To 
separate the NPC, the gradient was centrifuged for 20 min. at 2000 rpm without brake to 
avoid excessive deceleration which would mix the different phases. Afterwards, the 
interphase, containing the lymphocytes, was aspirated using a Pasteur pipette and 
transferred to a 50 ml falcon tube preloaded with 20 ml PBS. To remove remaining percoll 
the cells were centrifuged at 1500 rpm for 10 min. (with brake). The supernatant was 
discarded and the cells resuspended in 10 ml erythrocyte lysis buffer, incubated for 5 min. at 
RT and centrifuged for 5 min. at 1500 rpm. Following removal of the supernatant, the cells 
were washed once with 10 ml PBS/1% FCS and centrifuged as described above. After this 
washing step, the supernatant was discarded again and the cells resuspended in 1 to 2 ml 
PBS/1% FCS, depending on the required volume. Lymphocytes could directly be used for 
counting and specific staining (see chapters: 7.7.2 Counting of isolated primary lymphocytes, 
7.7.5 Staining protocols for flow cytometry, 7.7.5.1 Surface staining of lymphocytes and 
7.7.5.3 Intracellular FoxP3 staining). 
 
7.7.2 Counting of isolated primary lymphocytes 
Isolated lymphocytes were counted either manually using a Fuchs-Rosenthal counting 
chamber or automatically using the Guava cell acquisition system (Merck Millipore). For 
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manual counting, 10 µl cell suspension were diluted with 90 µl Trypanblue to discriminate 
viable from dead cells. Following enumeration of cells within 3 separate squares (4 x 4 each) 
of the counting chamber, the mean was multiplied with the dilution factor, the chamber factor 
(5 for Fuchs-Rosenthal) and the total volume to calculate the total cell number. Manual 
counting was always done prior to adoptive transfer experiments, including in vivo CTL. 
For automatic counting, 40 µl cell suspension were diluted 1:10 in PBS/1% FCS and 
measured with the guava cell acquisition system (Merck, Millipore). The settings were 
adjusted, using FSC vs. SSC. The concentration of lymphocytes was calculated 
automatically by the system and was depicted in cells/ml. 
 
7.7.3 In vivo cytotoxic T lymphocyte (CTL) assay 
Upon successful clearance of an acute infection, a minor fraction of antigen specific CD8+ T 
cells develops a pool of memory cells (Obar et al., 2011). These cells differ from naïve cells, 
as they are more abundant, have migratory capacity and can be reactivated by lower 
amounts of antigen to perform specific killing of an antigen presenting target cell (Mueller et 
al., 2013). According to those capabilities, antigen clearance upon adoptive transfer should 
establish a T cell population which is potent in reacting against reoccurring antigen in vivo. 
To investigate the presence of those cells, an in vivo cytotoxic T lymphocyte assay was 
applied. In this assay, a mixture of peptide loaded (pulsed) target cells and unpulsed control 
cells labeled with different concentrations of a fluorescent dye, were transferred into recipient 
mice. A specific killing of target cells by memory cells can be analyzed by flow cytometry 
(Aichele et al., 1997). Lymphocytes from the spleen were isolated as described above (see 
chapter: 7.7.1.2 Isolation of primary murine lymphocytes from the spleen) and re-
suspendend in 20 ml RPMI medium. The cell suspension was divided equally into two 
separate tubes. Both tubes were refilled with RPMI medium to a total volume of 20 ml. The 
cells in one falcon tube were pulsed with target peptide by addition of 10 µg/ml Ova (Stock: 
10 mg/ml). The other cells remained unpulsed. Both cell fractions were incubated at 37°C, 
5% CO2 and maximal humidity of 95% for 45 min. Afterwards, both falcon tubes were filled 
with PBS to a total volume of 45 ml and centrifuged for 5 min. at 1500 rpm. The cells were 
washed again and resuspended in 5 ml PBS. The fraction which was pulsed with Ova was 
stained by addition of 0.69 mM CFSE to the cells, resulting in the CFSE high (CFSEhi) 
fraction. The unpulsed fraction was stained by 0.069 mM CFSE and thus labeled CFSE low 
(CFSElo). The cells were incubated for 10 min. at 37°C, 5% CO2 in the dark followed by 
supplementation with 10 ml RPMI medium. Then, the cells were incubated on ice for 5 min., 
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washed twice with PBS, counted and adjusted to 2 x 107 cells per 100 µl in PBS. CFSEhi 
and CFSElo cells were mixed in a 1:1 ratio and transferred to recipient mice by intravenous 
(i.v.) injection. To avoid unspecific immune reaction due to sex specific gene expression, 
male recipients only received cells from male donors and female recipients always received 
cells from female donors. 
The recipient mice were sacrificed 16 h upon transfer and the frequency of CFSEhi and 
CFSElo cells in the spleens was analyzed by flow cytometry using the LSRII (BD). 
To estimate the ratio of transferred CFSEhi vs. CFSElo cells before each transfer, an aliquot 
of 100 µl was analyzed by flow cytometry using the LSRII (BD). 
 
7.7.4 Magnetic isolation of splenocytes 
Splenocytes were isolated as described above in chapter 7.7.1.2 Isolation of primary murine 
lymphocytes from the spleen. 
For adoptive transfer experiments, the cells were counted using a Fuchs-Rosenthal (0,2 µm) 
or a Neubauer-Improved (0,1 µm) chamber and subsequently purified with a MACS CD8a+ 
T cell isolation kit (Miltenyi) according to manufacturer´s instructions. Briefly, the cells were 
adjusted to a concentration of 107 cells/40 µl PBS/1% FCS and supplemented with 10 µl 
biotin-antibody cocktail/107 cells. The suspension was mixed and incubated at 4°C for 
10 min. Upon incubation 30 µl buffer (PBS/1% FCS) and 20 µl anti-biotin-microbeads per 107 
cells were added. The cells were incubated for additional 15 min. at 4°C. The cells were 
washed by refilling the tube to 50 ml with PBS/1% FCS and centrifuged at 1500 rpm for 
5 min. Following washing, the cells were resuspended in 500 µl PBS/1% FCS per 108 cells 
and loaded onto an equilibrated LS-column (Miltenyi) for magnetic negative separation. 
Afterwards, the column was washed three times with 3 ml PBS/1% FCS. The flow-through 
(containing the negatively selected CD8+ T cells) was centrifuged at 1500 rpm for 5 min. and 
adjusted to a concentration of 5 x 106 cells/200 µl PBS. The cells were then transplanted into 
respective recipient mice by i.v. injection. Adoptive transfers were always performed with 
respect to sex specific differences. Thus, only OT-I cells isolated from males, were 
transplanted into males, while OT-I from females were transplanted into female recipients. 
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7.7.5 Staining protocols for flow cytometry 
7.7.5.1 Surface staining of lymphocytes 
To analyze the phenotype of immune cells isolated from liver, spleen and other lymphatic 
tissues, these were stained with different fluorescently labeled primary antibodies (AB) 
directed against a given molecule as specified in (Tab. 4). Per staining assay, 200 µl of the 
isolated cells from each tissue were transferred to a v-shaped 96-well microtiter plate and 
centrifuged at 1500 rpm for 5 min. The supernatant was discarded and the cells were 
resuspended in 150 µl FACS buffer (PBS/2% FCS) supplemented with 6 µg/ml FC-block to 
avoid unspecific interactions between the immune cells and the staining antibodies. Then, 
the cells were incubated for 10 to 15 min. at 4°C, centrifuged as described above and the 
supernatant discarded. 50 µl of a previously mixed staining solution, containing the AB of 
interest, were added to each well and the cells were incubated at 4°C for 30 to 60 min. 
Afterwards, each well was filled with 200 µl FACS buffer and the cells were centrifuged for 5 
min. at 1500 rpm. After removal of the supernatant, the cells were washed twice with FACS 
buffer and resuspended in 150µl FACS buffer. Prior acquisition at the LSRII cytometer (BD), 
the cell suspensions were transferred into a conical FACS tube, containing 150 µl preloaded 
FACS buffer. 
 
7.7.5.2 Cultivation and peptide stimulation of primary murine lymphocytes 
To investigate the potential of murine immune cells to produce effector cytokines upon 
intrahepatic immune responses, isolated cells from liver and spleen were cultivated in vitro in 
the presence of the target peptide. The cultivation was performed in RPMI medium (5% FCS, 
1% Pen/Strep, 1% Glutamine) in a cell incubator at 37°C, 5% CO2 and 95% humidity. Freshly 
isolated immune cells were adjusted in RPMI to a concentration of 1 x 106 cells/ml if isolated 
from the liver. Cells isolated from spleens were adjusted to a concentration of 5 x 106 cells/ml 
RPMI. 5 x 100 µl of each cell suspension were seeded into a 96-well plate (for liver cells a U-
shaped well plate was used, splenocytes were cultured in a flat bottom well plate). To 
specifically re-stimulate Ova specific CD8+ T cells, the culture medium was supplemented 
with 2,5 µg SIINFEKL peptide/ml (Stock: 100 mg/ml). As a positive control a duplicate of cells 
was stimulated unspecifically using 10 ng/ml phorbol 12-myristate 13-acetate (PMA) and 
1 µg/ml ionomycin. 2 h upon cultivation, the splenocytes were transferred to a v-shaped 
microtiter plate. Splenocytes and liver cells were centrifuged at 1500 rpm for 5 min., the 
supernatant was discarded and the cells were resuspended in RPMI supplemented with 
either 2,5 µg/ml SIINFEKL and 3 µg/ml Brefeldin A or 10 ng/ml PMA, 1 µg/ml ionomycin and 
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3 µg/ml Brefeldin A. Brefeldin A was added to impair secretion of cytokines, as this chemical 
blocks the transport of vesicles from the ER to the Golgi apparatus. Cells were cultured in the 
presence of both, respective stimuli and Brefeldin A at 37°C for a minimum of 5 and a 
maximum of 7 h and then transferred to 4°C or directly processed. The surface staining was 
performed as described before (see chapters: 7.7.5 Staining protocols for flow cytometry 
7.7.5.1 Surface staining of lymphocytes). After removing unbound AB by washing, the cells 
were fixed and permeabilized by resuspension in 100 µl Cytofix/Cytoperm™ (BD)/well 
followed by an incubation for 20 min. at 4°C in the dark. Permeabilized cells were washed 
twice with BD Perm/Wash™ buffer (diluted 1:10 in ddH2O) which was also used as AB 
diluent. Finally, the cells were incubated for a minimum of 30 min. in the presence of the AB 
against the respective cytokine at 4°C and washed twice with FACS buffer. Cells were 
resuspended in 150 µl FACS buffer and analyzed by flow cytometry using the LSRII (BD). 
 
7.7.5.3 Intracellular FoxP3 staining 
The expression of the transcription factor FoxP3 has been shown to be exclusive for CD4+ 
regulatory T cells (Treg) (Fontenot et al., 2003; Fontenot & Rudensky, 2005). To gain insight 
into the regulative capacities of those cells during hepatitis or development of autoregulative 
cells in OT-II x Ova x Cre mice, those cells were also analyzed. Isolated lymphocytes (for 
more information see chapters: 7.7.1.1 Isolation of primary murine lymphocytes from liver 
draining lymph nodes, 7.7.1.2 Isolation of primary murine lymphocytes from the spleen and 
7.7.1.3 Isolation of primary murine lymphocytes from the liver) were stained first with the 
LIVE/DEAD® Fixable Near IR Dead cell stain kit (Invitrogen). This excludes false positive 
signals originating from dead cells as they are prone to bind antibodies unspecifically. Cells 
were washed with PBS and stained with 50 µl solution (1:500 Live/Dead stain in PBS) for 
30 min. at 4°C. Afterwards, the cells were washed with FACS buffer and stained with 
antibodies against the surface markers CD4, CD8, CD25 as described above (7.7.5 Staining 
protocols for flow cytometry and 7.7.5.1 Surface staining of lymphocytes). To specifically 
label the intracellular located transcription factor FoxP3, cells were resuspended in 200 µl of 
a freshly prepared fixation/permeabilization working solution (eBioscience) and incubated at 
4°C for 1 to 18 h. Afterwards, the samples were washed with 400 µl permeabilization buffer 
and then further incubated for 15 min. at 4°C in 50 µl permeabilization buffer, containing 
40 µg/ml rat IgG which was used as an intracellular blocking reagent. A PE-conjugated anti-
FoxP3 AB was diluted 1:250 in permeabilization buffer. 50 µl of this antibody solution were 
added to the permeabilized cells and they were incubated for additional 30 min. at 4°C. 
Methods 
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Afterwards, the cells were washed twice with 400 µl permeabilization buffer, resuspended in 
150 µl FACS buffer and acquired on the LSRII (BD). 
 
 7.8 Statistical analysis 
Data are represented as mean of biological replicates in groups of mice ± standard deviation 
(SD) if groups are n≥3. To compare the variation of two different data sets, Mann-Whitney U 
test was used if n≥4. Significant differences between sets are considered for p-values: 
* p≤0,05; ** p≤0,01; *** p≤0,001 and **** p≤0,0001. 
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